Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended |
Mar. 31, 2014 | |
Document and Entity Information | ' |
Entity Registrant Name | 'RAMBUS INC |
Entity Central Index Key | '0000917273 |
Current Fiscal Year End Date | '--12-31 |
Entity Filer Category | 'Accelerated Filer |
Document Type | '10-Q |
Document Period End Date | 31-Mar-14 |
Document Fiscal Year Focus | '2014 |
Document Fiscal Period Focus | 'Q1 |
Amendment Flag | 'false |
Entity Current Reporting Status | 'Yes |
Entity Common Stock, Shares Outstanding | 113,744,776 |
CONDENSED_CONSOLIDATED_BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash and cash equivalents | $346,576 | $338,696 |
Marketable securities | 56,848 | 48,966 |
Accounts receivable | 7,816 | 2,251 |
Prepaids and other current assets | 8,766 | 8,253 |
Deferred taxes | 1,009 | 205 |
Total current assets | 421,015 | 398,371 |
Intangible assets, net | 109,260 | 117,172 |
Goodwill | 116,899 | 116,899 |
Property, plant and equipment, net | 70,110 | 72,642 |
Deferred taxes, long-term | 643 | 4,797 |
Other assets | 3,071 | 3,498 |
Total assets | 720,998 | 713,379 |
Current liabilities: | ' | ' |
Accounts payable | 5,555 | 7,001 |
Accrued salaries and benefits | 27,257 | 33,448 |
Convertible notes, short-term | 168,658 | 164,047 |
Other accrued liabilities | 8,171 | 8,346 |
Total current liabilities | 209,641 | 212,842 |
Convertible notes, long-term | 110,962 | 109,629 |
Long-term imputed financing obligation | 39,295 | 39,349 |
Long-term income taxes payable | 1,905 | 6,561 |
Other long-term liabilities | 7,210 | 4,769 |
Total liabilities | 369,013 | 373,150 |
Commitments and contingencies (Notes 9 and 14) | ' | ' |
Stockholders’ equity: | ' | ' |
Convertible preferred stock, $.001 par value: Authorized: 5,000,000 shares Issued and outstanding: no shares at March 31, 2014 and December 31, 2013 | 0 | 0 |
Common stock, $.001 par value: Authorized: 500,000,000 shares Issued and outstanding: 113,744,776 shares at March 31, 2014 and 113,459,390 shares at December 31, 2013 | 114 | 113 |
Additional paid-in capital | 1,132,092 | 1,128,148 |
Accumulated deficit | -779,924 | -787,727 |
Accumulated other comprehensive loss | -297 | -305 |
Total stockholders’ equity | 351,985 | 340,229 |
Total liabilities and stockholders’ equity | $720,998 | $713,379 |
CONDENSED_CONSOLIDATED_BALANCE1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
Stockholders’ equity: | ' | ' |
Convertible preferred stock, par value (in dollars per share) | $0.00 | $0.00 |
Convertible preferred stock, Authorized shares | 5,000,000 | 5,000,000 |
Convertible preferred stock, Issued shares | 0 | 0 |
Convertible preferred stock, Outstanding shares | 0 | 0 |
Common stock, par value (in dollars per share) | $0.00 | $0.00 |
Common stock, Authorized shares | 500,000,000 | 500,000,000 |
Common stock, Issued shares | 113,744,776 | 113,459,390 |
Common stock, Outstanding shares | 113,744,776 | 113,459,390 |
CONDENSED_CONSOLIDATED_STATEME
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | |||
In Thousands, except Per Share data, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | ||
Revenue: | ' | ' | ||
Royalties | $73,637 | $66,222 | ||
Contract and other revenue | 4,651 | 644 | ||
Total revenue | 78,288 | 66,866 | ||
Operating costs and expenses: | ' | ' | ||
Cost of revenue | 10,022 | [1] | 6,534 | [1] |
Research and development | 26,898 | [1] | 32,848 | [1] |
Marketing, general and administrative | 18,820 | [1] | 25,122 | [1] |
Gain from sale of intellectual property | -170 | -1,285 | ||
Restructuring charges | 39 | 2,206 | ||
Gain from settlement | -510 | 0 | ||
Total operating costs and expenses | 55,099 | 65,425 | ||
Operating income (loss) | 23,189 | 1,441 | ||
Interest income and other income (expense), net | 13 | -20 | ||
Interest expense | -9,926 | -7,312 | ||
Interest and other income (expense), net | -9,913 | -7,332 | ||
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest | 13,276 | -5,891 | ||
Provision for income taxes | 5,472 | 4,511 | ||
Net income (loss) | $7,804 | ($10,402) | ||
Net income (loss) per share: | ' | ' | ||
Earnings Per Share, Basic | $0.07 | ($0.09) | ||
Earnings Per Share, Diluted | $0.07 | ($0.09) | ||
Weighted average shares used in per share calculation: | ' | ' | ||
Basic (in shares) | 113,590 | 111,599 | ||
Diluted (in shares) | 116,629 | 111,599 | ||
[1] | Includes stock-based compensation |
CONDENSED_CONSOLIDATED_STATEME1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Cost of revenue | ' | ' |
Stock-based compensation | $7 | $0 |
Research and development | ' | ' |
Stock-based compensation | 1,311 | 1,876 |
Marketing, general and administrative | ' | ' |
Stock-based compensation | $1,581 | $3,072 |
CONDENSED_CONSOLIDATED_STATEME2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Statement of Comprehensive Income [Abstract] | ' | ' |
Net income (loss) | $7,804 | ($10,402) |
Other comprehensive income (loss): | ' | ' |
Unrealized gain (loss) on marketable securities, net of tax | 8 | -14 |
Total comprehensive income (loss) | $7,812 | ($10,416) |
CONDENSED_CONSOLIDATED_STATEME3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Cash flows from operating activities: | ' | ' |
Net income (loss) | $7,804 | ($10,402) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ' | ' |
Stock-based compensation | 2,899 | 4,948 |
Depreciation | 3,481 | 3,791 |
Amortization of intangible assets | 6,797 | 7,040 |
Non-cash interest expense and amortization of convertible debt issuance costs | 6,242 | 4,089 |
Deferred income taxes | 5,967 | 263 |
Non-cash restructuring | 0 | 653 |
Gain from sale of intellectual property | -170 | -1,285 |
Change in operating assets and liabilities, net of effects of acquisitions: | ' | ' |
Accounts receivable | -5,565 | 469 |
Prepaid expenses and other assets | -183 | 2,965 |
Accounts payable | 749 | -2,243 |
Accrued salaries and benefits and other accrued liabilities | -6,682 | 4,646 |
Income taxes payable | -4,828 | 378 |
Net cash provided by operating activities | 16,511 | 15,312 |
Cash flows from investing activities: | ' | ' |
Purchases of property, plant and equipment | -3,145 | -3,703 |
Acquisition of intangible assets | 0 | -1,875 |
Purchases of marketable securities | -34,050 | -36,699 |
Maturities of marketable securities | 26,050 | 33,250 |
Proceeds from sale of intellectual property | 1,250 | 2,000 |
Net cash used in investing activities | -9,895 | -7,027 |
Cash flows from financing activities: | ' | ' |
Proceeds received from issuance of common stock under employee stock plans | 1,352 | 0 |
Principal payments against lease financing obligation | -60 | -26 |
Payments under installment payment arrangement | -28 | -28 |
Net cash provided by (used in) financing activities | 1,264 | -54 |
Net increase in cash and cash equivalents | 7,880 | 8,231 |
Cash and cash equivalents at beginning of period | 338,696 | 148,984 |
Cash and cash equivalents at end of period | 346,576 | 157,215 |
Non-cash investing and financing activities during the period: | ' | ' |
Property, plant and equipment received and accrued in accounts payable and other accrued liabilities | $280 | $166 |
Basis_of_Presentation
Basis of Presentation | 3 Months Ended |
Mar. 31, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Basis of Presentation | ' |
Basis of Presentation | |
The accompanying unaudited condensed consolidated financial statements include the accounts of Rambus Inc. (“Rambus” or the “Company”) and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in the accompanying unaudited condensed consolidated financial statements. Investments in entities with less than 20% ownership or in which the Company does not have the ability to significantly influence the operations of the investee are being accounted for using the cost method and are included in other assets. | |
In the opinion of management, the unaudited condensed consolidated financial statements include all adjustments (consisting only of normal recurring items) necessary to state fairly the financial position and results of operations for each interim period presented. Interim results are not necessarily indicative of results for a full year. | |
The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) applicable to interim financial information. Certain information and Note disclosures included in the financial statements prepared in accordance with generally accepted accounting principles have been omitted in these interim statements pursuant to such SEC rules and regulations. The information included in this Form 10-Q should be read in conjunction with the consolidated financial statements and notes thereto in Form 10-K for the year ended December 31, 2013. | |
Operating Segment Definitions | |
Operating segments are based upon Rambus' internal organization structure, the manner in which its operations are managed, the criteria used by its Chief Operating Decision Maker ("CODM") to evaluate segment performance and availability of separate financial information regularly reviewed for resource allocation and performance assessment. | |
The Company determined its CODM to be the Chief Executive Officer and determined its operating segments to be: (1) Memory and Interface Division ("MID"), which focuses on the design, development and licensing of technology that is related to memory and interfaces; (2) Cryptography Research Inc. ("CRI"), which focuses on the design, development and licensing of technologies for chip and system security and anti-counterfeiting; (3) Lighting and Display Technologies ("LDT"), which focuses on the design, development and licensing of technologies for lighting; and (4) Chief Technology Office ("CTO"), which focuses on the design, development and productization of emerging technologies. | |
For the three months ended March 31, 2014 and 2013, only MID, CRI and CTO were reportable segments as each of them met the quantitative thresholds for disclosure as a reportable segment. The results of the remaining other operating segments were combined and shown under “Other.” | |
Reclassifications | |
Certain prior periods' amounts were reclassified to conform to the current year’s presentation. None of these reclassifications had an impact on reported net income (loss) for any of the periods presented. |
Recent_Accounting_Pronouncemen
Recent Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2014 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | ' |
Recent Accounting Pronouncements | ' |
Recent Accounting Pronouncements | |
In April 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity," which changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. The new accounting standards update becomes effective for the Company on January 1, 2015. Early adoption is permitted for new disposals (or new classifications as held for sale) that have not been reported in financial statements previously issued or available for issuance. The Company does not expect that this guidance will have an impact on its financial position, results of operations or cash flows as the Company does not currently have discontinued operations. | |
In July 2013, the FASB issued ASU No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” ("ASU 2013-11"). ASU 2013-11 provides guidance on the presentation of unrecognized tax benefits. ASU 2013-11 requires presenting an unrecognized tax benefit or a portion of an unrecognized tax benefit as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carry forward, except to the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. This accounting standards update became effective for the Company on January 1, 2014 and was applied prospectively to unrecognized tax benefits that existed at the effective date with retrospective application permitted. Upon adoption of this guidance, the Company reclassified $4.7 million from a long-term tax liability to a reduction of a deferred tax asset. |
Earnings_Loss_Per_Share
Earnings (Loss) Per Share | 3 Months Ended | ||||||||
Mar. 31, 2014 | |||||||||
Earnings Per Share [Abstract] | ' | ||||||||
Earnings (Loss) Per Share | ' | ||||||||
Earnings (Loss) Per Share | |||||||||
Basic earnings (loss) per share is calculated by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated by dividing the earnings by the weighted average number of common shares and potentially dilutive securities outstanding during the period. Potentially dilutive common shares consist of incremental common shares issuable upon exercise of stock options, employee stock purchases, restricted stock and restricted stock units and shares issuable upon the conversion of convertible notes. The dilutive effect of outstanding shares is reflected in diluted earnings per share by application of the treasury stock method. This method includes consideration of the amounts to be paid by the employees, the amount of excess tax benefits that would be recognized in equity if the instrument was exercised and the amount of unrecognized stock-based compensation related to future services. No potential dilutive common shares are included in the computation of any diluted per share amount when a net loss is reported. | |||||||||
The following table sets forth the computation of basic and diluted net income (loss) per share: | |||||||||
Three Months Ended March 31, | |||||||||
2014 | 2013 | ||||||||
Net income (loss) per share: | (In thousands, except per share amounts) | ||||||||
Numerator: | |||||||||
Net income (loss) | $ | 7,804 | $ | (10,402 | ) | ||||
Denominator: | |||||||||
Weighted-average shares outstanding - basic | 113,590 | 111,599 | |||||||
Effect of potential dilutive common shares | 3,039 | — | |||||||
Weighted-average shares outstanding - diluted | 116,629 | 111,599 | |||||||
Basic net income (loss) per share | $ | 0.07 | $ | (0.09 | ) | ||||
Diluted net income (loss) per share | $ | 0.07 | $ | (0.09 | ) | ||||
For the three months ended March 31, 2014 and 2013, options to purchase approximately 6.9 million and 12.9 million shares, respectively, were excluded from the calculation because they were anti-dilutive after considering proceeds from exercise, taxes and related unrecognized stock-based compensation expense. For the three months ended March 31, 2013, an additional 6.4 million potentially dilutive shares have been excluded from the weighted average dilutive shares because there was a net loss for the period. |
Intangible_Asset_and_Goodwill
Intangible Asset and Goodwill | 3 Months Ended | ||||||||||||||||
Mar. 31, 2014 | |||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | ||||||||||||||||
Intangible Asset and Goodwill | ' | ||||||||||||||||
Intangible Assets and Goodwill | |||||||||||||||||
Goodwill | |||||||||||||||||
The following tables present goodwill information for each of the reportable segments for the three months ended March 31, 2014: | |||||||||||||||||
Reportable Segment: | December 31, | Additions to Goodwill | Impairment Charge of Goodwill | March 31, | |||||||||||||
2013 | 2014 | ||||||||||||||||
(In thousands) | |||||||||||||||||
MID | $ | 19,905 | $ | — | $ | — | $ | 19,905 | |||||||||
CTO | — | — | — | — | |||||||||||||
CRI | 96,994 | — | — | 96,994 | |||||||||||||
Other | — | — | — | — | |||||||||||||
Total | $ | 116,899 | $ | — | $ | — | $ | 116,899 | |||||||||
As of | |||||||||||||||||
March 31, 2014 | |||||||||||||||||
Reportable Segment: | Gross Carrying Amount | Accumulated Impairment Losses | Net Carrying Amount | ||||||||||||||
(In thousands) | |||||||||||||||||
MID | $ | 19,905 | $ | — | $ | 19,905 | |||||||||||
CTO | 8,070 | (8,070 | ) | — | |||||||||||||
CRI | 96,994 | — | 96,994 | ||||||||||||||
Other | 13,700 | (13,700 | ) | — | |||||||||||||
Total | $ | 138,669 | $ | (21,770 | ) | $ | 116,899 | ||||||||||
Intangible Assets | |||||||||||||||||
The components of the Company’s intangible assets as of March 31, 2014 and December 31, 2013 were as follows: | |||||||||||||||||
As of March 31, 2014 | |||||||||||||||||
Useful Life | Gross Carrying | Accumulated | Net Carrying | ||||||||||||||
Amount | Amortization | Amount | |||||||||||||||
(In thousands) | |||||||||||||||||
Existing technology | 3 to 10 years | $ | 185,321 | $ | (86,476 | ) | $ | 98,845 | |||||||||
Customer contracts and contractual relationships | 1 to 10 years | 31,093 | (20,695 | ) | 10,398 | ||||||||||||
Non-compete agreements | 3 years | 300 | (283 | ) | 17 | ||||||||||||
Total intangible assets | $ | 216,714 | $ | (107,454 | ) | $ | 109,260 | ||||||||||
As of December 31, 2013 | |||||||||||||||||
Useful Life | Gross Carrying | Accumulated | Net Carrying | ||||||||||||||
Amount | Amortization | Amount | |||||||||||||||
(In thousands) | |||||||||||||||||
Existing technology | 3 to 10 years | $ | 186,202 | $ | (80,961 | ) | $ | 105,241 | |||||||||
Customer contracts and contractual relationships | 1 to 10 years | 31,093 | (19,204 | ) | 11,889 | ||||||||||||
Non-compete agreements | 3 years | 300 | (258 | ) | 42 | ||||||||||||
Total intangible assets | $ | 217,595 | $ | (100,423 | ) | $ | 117,172 | ||||||||||
During the three months ended March 31, 2014, the Company did not purchase any intangible assets. During the three months ended March 31, 2014, the Company sold portfolios of its intellectual property covering wireless and other technologies for $2.5 million and the related gain was recorded as gain from sale of intellectual property in the condensed consolidated statements of operations. | |||||||||||||||||
The favorable contracts (included in customer contracts and contractual relationships) are acquired patent licensing agreements where the Company has no performance obligations. Cash received from these acquired favorable contracts reduces the favorable contract intangible asset. For the three months ended March 31, 2014 and 2013, the Company received $0.9 million and $1.4 million related to the favorable contracts, respectively. As of March 31, 2014 and December 31, 2013, the net balance of the favorable contract intangible assets was $0.1 million and $1.0 million, respectively. | |||||||||||||||||
Amortization expense for intangible assets for the three months ended March 31, 2014 and 2013 was $6.8 million and $7.0 million, respectively. The estimated future amortization expense of intangible assets as of March 31, 2014 was as follows (amounts in thousands): | |||||||||||||||||
Years Ending December 31: | Amount | ||||||||||||||||
2014 (remaining 9 months) | $ | 19,846 | |||||||||||||||
2015 | 25,098 | ||||||||||||||||
2016 | 24,335 | ||||||||||||||||
2017 | 23,734 | ||||||||||||||||
2018 | 10,827 | ||||||||||||||||
Thereafter | 5,420 | ||||||||||||||||
$ | 109,260 | ||||||||||||||||
It is reasonably possible that the businesses could perform significantly below the Company's expectations or a deterioration of market and economic conditions could occur. This would adversely impact the Company's ability to meet its projected results, which could cause the goodwill in any of its reporting units or long-lived assets in any of its asset groups to become impaired. Significant differences between these estimates and actual cash flows could materially affect the Company's future financial results. If the reporting units are not successful in commercializing new business arrangements, if the businesses are unsuccessful in signing new license agreements or renewing their existing license agreements, or if the Company is unsuccessful in managing its costs, the revenue and income for these reporting units could adversely and materially deviate from their historical trends and could cause goodwill or long-lived assets to become impaired. If the Company determines that its goodwill or long-lived assets are impaired, it would be required to record a non-cash charge that could have a material adverse effect on its results of operations and financial position. |
Segments_and_Major_Customers
Segments and Major Customers | 3 Months Ended | |||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||||||
Segments and Major Customers | ' | |||||||||||||||||||
Segments and Major Customers | ||||||||||||||||||||
For the three months ended March 31, 2014 and 2013, MID, CRI and CTO were reportable segments as each of them met the quantitative thresholds for disclosure as a reportable segment. The results of the remaining operating segment were shown under “Other.” | ||||||||||||||||||||
The Company evaluates the performance of its segments based on segment operating income (loss), which is defined as revenue minus segment operating expenses. Segment operating expenses are comprised of direct operating expenses. | ||||||||||||||||||||
Segment operating expenses do not include marketing, general and administrative expenses and the allocation of certain expenses managed at the corporate level, such as stock-based compensation, amortization, and certain bonus and acquisition costs. The “Reconciling Items” category includes these unallocated marketing, general and administrative expenses as well as corporate level expenses. The presentation of the three months ended March 31, 2013 segment data has been updated accordingly to conform with the 2014 segment operating income (loss) definition. | ||||||||||||||||||||
The tables below present reported segment operating income (loss) for the three months ended March 31, 2014 and 2013, respectively. | ||||||||||||||||||||
For the Three Months Ended March 31, 2014 | ||||||||||||||||||||
MID | CRI | CTO | Other | Total | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
Revenues | $ | 61,156 | $ | 12,903 | $ | — | $ | 4,229 | $ | 78,288 | ||||||||||
Segment operating expenses | 9,920 | 7,629 | 4,271 | 4,382 | 26,202 | |||||||||||||||
Segment operating income (loss) | $ | 51,236 | $ | 5,274 | $ | (4,271 | ) | $ | (153 | ) | $ | 52,086 | ||||||||
Reconciling items | (28,897 | ) | ||||||||||||||||||
Operating income | $ | 23,189 | ||||||||||||||||||
Interest and other income (expense), net | (9,913 | ) | ||||||||||||||||||
Income before income taxes | $ | 13,276 | ||||||||||||||||||
For the Three Months Ended March 31, 2013 | ||||||||||||||||||||
MID | CRI | CTO | Other | Total | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
Revenues | $ | 59,674 | $ | 6,883 | $ | — | $ | 309 | $ | 66,866 | ||||||||||
Segment operating expenses | 9,884 | 4,888 | 7,171 | 3,629 | 25,572 | |||||||||||||||
Segment operating income (loss) | $ | 49,790 | $ | 1,995 | $ | (7,171 | ) | $ | (3,320 | ) | $ | 41,294 | ||||||||
Reconciling items | (39,853 | ) | ||||||||||||||||||
Operating income | $ | 1,441 | ||||||||||||||||||
Interest and other income (expense), net | (7,332 | ) | ||||||||||||||||||
Loss before income taxes | $ | (5,891 | ) | |||||||||||||||||
The Company’s CODM does not review information regarding assets on an operating segment basis. Additionally, the Company does not record intersegment revenue or expense. | ||||||||||||||||||||
Revenue from the Company’s major customers representing 10% or more of total revenue for the three months ended March 31, 2014 and 2013, respectively, was as follows: | ||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||
March 31, | ||||||||||||||||||||
Customer | 2014 | 2013 | ||||||||||||||||||
Customer A (MID and CRI reportable segments) | 19 | % | 33 | % | ||||||||||||||||
Customer B (MID reportable segment) | 15 | % | * | |||||||||||||||||
Customer C (MID reportable segment) | 12 | % | * | |||||||||||||||||
Customer D (MID reportable segment) | * | 15 | % | |||||||||||||||||
Customer E (MID reportable segment) | * | 10 | % | |||||||||||||||||
_________________________________________ | ||||||||||||||||||||
* Customer accounted for less than 10% of total revenue in the period | ||||||||||||||||||||
Revenue from customers in the geographic regions based on the location of customers' headquarters is as follows: | ||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||
March 31, | ||||||||||||||||||||
(In thousands) | 2014 | 2013 | ||||||||||||||||||
South Korea | $ | 26,853 | $ | 22,025 | ||||||||||||||||
USA | 28,674 | 25,569 | ||||||||||||||||||
Japan | 9,255 | 14,609 | ||||||||||||||||||
Europe | 8,563 | 2,127 | ||||||||||||||||||
Canada | 1,824 | 1,786 | ||||||||||||||||||
Asia-Other | 3,119 | 750 | ||||||||||||||||||
Total | $ | 78,288 | $ | 66,866 | ||||||||||||||||
Marketable_Securities
Marketable Securities | 3 Months Ended | |||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||
Available-for-sale Securities [Abstract] | ' | |||||||||||||||||||
Marketable Securities | ' | |||||||||||||||||||
Marketable Securities | ||||||||||||||||||||
Rambus invests its excess cash and cash equivalents primarily in U.S. government sponsored obligations, commercial paper, corporate notes and bonds, money market funds and municipal notes and bonds that mature within three years. As of March 31, 2014 and December 31, 2013, all of the Company’s cash equivalents and marketable securities had a remaining maturity of less than one year. | ||||||||||||||||||||
All cash equivalents and marketable securities are classified as available-for-sale. Total cash, cash equivalents and marketable securities are summarized as follows: | ||||||||||||||||||||
As of March 31, 2014 | ||||||||||||||||||||
(In thousands) | Fair Value | Amortized | Gross | Gross | Weighted | |||||||||||||||
Cost | Unrealized | Unrealized | Rate of | |||||||||||||||||
Gains | Losses | Return | ||||||||||||||||||
Money market funds | $ | 317,769 | $ | 317,769 | $ | — | $ | — | 0.01 | % | ||||||||||
Corporate notes, bonds and commercial paper | 58,347 | 58,355 | 1 | (9 | ) | 0.13 | % | |||||||||||||
Total cash equivalents and marketable securities | 376,116 | 376,124 | 1 | (9 | ) | |||||||||||||||
Cash | 27,308 | 27,308 | — | — | ||||||||||||||||
Total cash, cash equivalents and marketable securities | $ | 403,424 | $ | 403,432 | $ | 1 | $ | (9 | ) | |||||||||||
As of December 31, 2013 | ||||||||||||||||||||
(In thousands) | Fair Value | Amortized | Gross | Gross | Weighted | |||||||||||||||
Cost | Unrealized | Unrealized | Rate of | |||||||||||||||||
Gains | Losses | Return | ||||||||||||||||||
Money market funds | $ | 300,605 | $ | 300,605 | $ | — | $ | — | 0.01 | % | ||||||||||
Corporate notes, bonds and commercial paper | 58,492 | 58,507 | — | (15 | ) | 0.15 | % | |||||||||||||
Total cash equivalents and marketable securities | 359,097 | 359,112 | — | (15 | ) | |||||||||||||||
Cash | 28,565 | 28,565 | — | — | ||||||||||||||||
Total cash, cash equivalents and marketable securities | $ | 387,662 | $ | 387,677 | $ | — | $ | (15 | ) | |||||||||||
Available-for-sale securities are reported at fair value on the balance sheets and classified as follows: | ||||||||||||||||||||
As of | ||||||||||||||||||||
March 31, | December 31, | |||||||||||||||||||
2014 | 2013 | |||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Cash equivalents | $ | 319,268 | $ | 310,131 | ||||||||||||||||
Short term marketable securities | 56,848 | 48,966 | ||||||||||||||||||
Total cash equivalents and marketable securities | 376,116 | 359,097 | ||||||||||||||||||
Cash | 27,308 | 28,565 | ||||||||||||||||||
Total cash, cash equivalents and marketable securities | $ | 403,424 | $ | 387,662 | ||||||||||||||||
The Company continues to invest in highly rated quality, highly liquid debt securities. As of March 31, 2014, these securities have a remaining maturity of less than one year. The Company holds all of its marketable securities as available-for-sale, marks them to market, and regularly reviews its portfolio to ensure adherence to its investment policy and to monitor individual investments for risk analysis, proper valuation, and unrealized losses that may be other than temporary. | ||||||||||||||||||||
The estimated fair value of cash equivalents and marketable securities classified by the length of time that the securities have been in a continuous unrealized loss position at March 31, 2014 and December 31, 2013 are as follows: | ||||||||||||||||||||
Fair Value | Gross Unrealized Loss | |||||||||||||||||||
March 31, | December 31, | March 31, | December 31, | |||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||
(In thousands) | ||||||||||||||||||||
Less than one year | ||||||||||||||||||||
Corporate notes, bonds and commercial paper | $ | 43,151 | $ | 53,491 | $ | (9 | ) | $ | (15 | ) | ||||||||||
The gross unrealized loss at March 31, 2014 and December 31, 2013 was not material in relation to the Company’s total available-for-sale portfolio. The gross unrealized loss can be primarily attributed to a combination of market conditions as well as the demand for and duration of the corporate notes and bonds. The Company has no intent to sell, there is no requirement to sell and the Company believes that it can recover the amortized cost of these investments. The Company has found no evidence of impairment due to credit losses in its portfolio. Therefore, these unrealized losses were recorded in other comprehensive income (loss). However, the Company cannot provide any assurance that its portfolio of cash, cash equivalents and marketable securities will not be impacted by adverse conditions in the financial markets, which may require the Company in the future to record an impairment charge for credit losses which could adversely impact its financial results. | ||||||||||||||||||||
See Note 7, “Fair Value of Financial Instruments,” for discussion regarding the fair value of the Company’s cash equivalents and marketable securities. |
Fair_Value_of_Financial_Instru
Fair Value of Financial Instruments | 3 Months Ended | ||||||||||||||||||||||||
Mar. 31, 2014 | |||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ' | ||||||||||||||||||||||||
Fair Value of Financial Instruments | ' | ||||||||||||||||||||||||
Fair Value of Financial Instruments | |||||||||||||||||||||||||
The Company reviews the pricing inputs by obtaining prices from a different source for the same security on a sample of its portfolio. The Company has not adjusted the pricing inputs it has obtained. The following table presents the financial instruments that are carried at fair value and summarizes the valuation of its cash equivalents and marketable securities by the above pricing levels as of March 31, 2014 and December 31, 2013: | |||||||||||||||||||||||||
As of March 31, 2014 | |||||||||||||||||||||||||
Total | Quoted | Significant | Significant | ||||||||||||||||||||||
Market | Other | Unobservable | |||||||||||||||||||||||
Prices in | Observable | Inputs | |||||||||||||||||||||||
Active | Inputs | (Level 3) | |||||||||||||||||||||||
Markets | (Level 2) | ||||||||||||||||||||||||
(Level 1) | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||
Money market funds | $ | 317,769 | $ | 317,769 | $ | — | $ | — | |||||||||||||||||
Corporate notes, bonds and commercial paper | 58,347 | — | 58,347 | — | |||||||||||||||||||||
Total available-for-sale securities | $ | 376,116 | $ | 317,769 | $ | 58,347 | $ | — | |||||||||||||||||
As of December 31, 2013 | |||||||||||||||||||||||||
Total | Quoted | Significant | Significant | ||||||||||||||||||||||
Market | Other | Unobservable | |||||||||||||||||||||||
Prices in | Observable | Inputs | |||||||||||||||||||||||
Active | Inputs | (Level 3) | |||||||||||||||||||||||
Markets | (Level 2) | ||||||||||||||||||||||||
(Level 1) | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||
Money market funds | $ | 300,605 | $ | 300,605 | $ | — | $ | — | |||||||||||||||||
Corporate notes, bonds and commercial paper | 58,492 | — | 58,492 | — | |||||||||||||||||||||
Total available-for-sale securities | $ | 359,097 | $ | 300,605 | $ | 58,492 | $ | — | |||||||||||||||||
The following table presents the financial instruments that are measured on a nonrecurring basis as of March 31, 2014: | |||||||||||||||||||||||||
As of March 31, 2014 | |||||||||||||||||||||||||
(in thousands) | Carrying Value | Quoted market prices in active markets (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Impairment charges for the three months ended March 31, 2014 | ||||||||||||||||||||
Investment in non-marketable securities | $ | 600 | $ | — | $ | — | $ | 600 | $ | — | |||||||||||||||
The Company monitors its investments for other-than-temporary impairment and records appropriate reductions in carrying value when necessary. The Company monitors its investments for other-than-temporary losses by considering current factors, including the economic environment, market conditions, operational performance and other specific factors relating to the business underlying the investment, reductions in carrying values when necessary and the Company’s ability and intent to hold the investment for a period of time which may be sufficient for anticipated recovery in the market. Any other-than-temporary loss is reported under “Interest and other income (expense), net” in the condensed consolidated statement of operations. For the three months ended March 31, 2014 and 2013, the Company did not incur any impairment loss on its investments. | |||||||||||||||||||||||||
Additionally, the Company cannot provide any assurance that its non-marketable equity security will not be further impacted by adverse changes in the general market conditions or deterioration in business prospects of the investee, which may require the Company in the future to record additional impairment charges which could adversely impact its financial results. | |||||||||||||||||||||||||
For the three months ended March 31, 2014 and 2013, there were no transfers of financial instruments between different categories of fair value. | |||||||||||||||||||||||||
The following table presents the financial instruments that are not carried at fair value but require fair value disclosure as of March 31, 2014 and December 31, 2013: | |||||||||||||||||||||||||
As of March 31, 2014 | As of December 31, 2013 | ||||||||||||||||||||||||
(In thousands) | Face | Carrying | Fair Value | Face | Carrying | Fair Value | |||||||||||||||||||
Value | Value | Value | Value | ||||||||||||||||||||||
5% Convertible Senior Notes due 2014 (the "2014 Notes") | $ | 172,500 | $ | 168,658 | $ | 173,846 | $ | 172,500 | $ | 164,047 | $ | 175,821 | |||||||||||||
1.125% Convertible Senior Notes due 2018 (the "2018 Notes") | $ | 138,000 | $ | 110,962 | $ | 155,824 | $ | 138,000 | $ | 109,629 | $ | 142,427 | |||||||||||||
The fair value of the convertible notes at each balance sheet date is determined based on recent quoted market prices for these notes which is a level two measurement. As discussed in Note 8, "Convertible Notes," as of March 31, 2014, the 2014 Notes and 2018 Notes are carried at their face value of $172.5 million and $138.0 million, respectively, less any unamortized debt discount. The carrying value of other financial instruments, including accounts receivable, accounts payable and other accrued liabilities, approximates fair value due to their short maturities. |
Convertible_Notes
Convertible Notes | 3 Months Ended | ||||||||
Mar. 31, 2014 | |||||||||
Debt Disclosure [Abstract] | ' | ||||||||
Convertible Notes | ' | ||||||||
Convertible Notes | |||||||||
The Company’s convertible notes are shown in the following table: | |||||||||
(In thousands) | As of March 31, 2014 | As of December 31, 2013 | |||||||
5% Convertible Senior Notes due 2014 | $ | 172,500 | $ | 172,500 | |||||
1.125% Convertible Senior Notes due 2018 | 138,000 | 138,000 | |||||||
Total principal amount of convertible notes | $ | 310,500 | $ | 310,500 | |||||
Unamortized discount - 2014 Notes | $ | (3,842 | ) | $ | (8,453 | ) | |||
Unamortized discount - 2018 Notes | (27,038 | ) | (28,371 | ) | |||||
Total unamortized discount | $ | (30,880 | ) | $ | (36,824 | ) | |||
Total convertible notes | $ | 279,620 | $ | 273,676 | |||||
Less current portion | 168,658 | 164,047 | |||||||
Total long-term convertible notes | $ | 110,962 | $ | 109,629 | |||||
The 2014 Notes are classified as a short-term liability as they will be due on June 15, 2014. | |||||||||
Interest expense related to the notes for the three months ended March 31, 2014 and 2013 was as follows: | |||||||||
Three Months Ended | |||||||||
March 31, | |||||||||
2014 | 2013 | ||||||||
(In thousands) | |||||||||
2014 Notes coupon interest at a rate of 5% | $ | 2,156 | $ | 2,157 | |||||
2014 Notes amortization of discount and debt issuance costs at an additional effective interest rate of 11.7% | 4,769 | 4,089 | |||||||
2018 Notes coupon interest at a rate of 1.125% | 388 | — | |||||||
2018 Notes amortization of discount and debt issuance costs at an additional effective interest rate of 5.5% | 1,473 | — | |||||||
Total interest expense on convertible notes | $ | 8,786 | $ | 6,246 | |||||
Commitments_and_Contingencies
Commitments and Contingencies | 3 Months Ended | |||||||||||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | ' | |||||||||||||||||||||||||||
Commitments and Contingencies | ' | |||||||||||||||||||||||||||
Commitments and Contingencies | ||||||||||||||||||||||||||||
As of March 31, 2014, the Company’s material contractual obligations were as follows (in thousands): | ||||||||||||||||||||||||||||
Total | Remainder of 2014 | 2015 | 2016 | 2017 | 2018 | Thereafter | ||||||||||||||||||||||
Contractual obligations (1) | ||||||||||||||||||||||||||||
Imputed financing obligation (2) | $ | 38,808 | $ | 4,422 | $ | 6,010 | $ | 6,156 | $ | 6,302 | $ | 6,447 | $ | 9,471 | ||||||||||||||
Leases and other contractual obligations | 7,118 | 2,399 | 2,118 | 1,243 | 1,018 | 340 | — | |||||||||||||||||||||
Software licenses (3) | 5,684 | 2,446 | 2,865 | 373 | — | — | — | |||||||||||||||||||||
Acquisition retention bonuses (4) | 16,749 | 16,679 | 70 | — | — | — | — | |||||||||||||||||||||
Convertible notes | 310,500 | 172,500 | — | — | — | 138,000 | — | |||||||||||||||||||||
Interest payments related to convertible notes | 11,300 | 5,089 | 1,553 | 1,553 | 1,553 | 1,552 | — | |||||||||||||||||||||
Total | $ | 390,159 | $ | 203,535 | $ | 12,616 | $ | 9,325 | $ | 8,873 | $ | 146,339 | $ | 9,471 | ||||||||||||||
_________________________________________ | ||||||||||||||||||||||||||||
-1 | The above table does not reflect possible payments in connection with uncertain tax benefits of approximately $20.0 million including $18.0 million recorded as a reduction of long-term deferred tax assets and $2.0 million in long-term income taxes payable as of March 31, 2014. As noted below in Note 13, “Income Taxes,” although it is possible that some of the unrecognized tax benefits could be settled within the next 12 months, the Company cannot reasonably estimate the outcome at this time. | |||||||||||||||||||||||||||
-2 | With respect to the imputed financing obligation, the main components of the difference between the amount reflected in the contractual obligations table and the amount reflected on the condensed consolidated balance sheets are the interest on the imputed financing obligation and the estimated common area expenses over the future periods. Additionally, the amount includes the amended Ohio lease and the amended Sunnyvale lease. | |||||||||||||||||||||||||||
-3 | The Company has commitments with various software vendors for non-cancellable license agreements generally having terms longer than one year. The above table summarizes those contractual obligations as of March 31, 2014 which are also presented on the Company’s condensed consolidated balance sheet under current and other long-term liabilities. | |||||||||||||||||||||||||||
-4 | In connection with acquisitions, the Company is obligated to pay retention bonuses to certain employees and contractors, subject to certain eligibility and acceleration provisions including the condition of employment. The remaining $16.7 million of CRI retention bonuses payable on June 3, 2014 can be paid in cash or stock at the Company’s election. | |||||||||||||||||||||||||||
Building lease expense was approximately $0.6 million and $0.9 million for the three months ended March 31, 2014 and 2013, respectively. Deferred rent of $1.3 million and $1.4 million as of March 31, 2014 and December 31, 2013, respectively, were included primarily in other long-term liabilities. | ||||||||||||||||||||||||||||
Indemnification | ||||||||||||||||||||||||||||
The Company enters into standard license agreements in the ordinary course of business. Although the Company does not indemnify most of its customers, there are times when an indemnification is a necessary means of doing business. Indemnification covers customers for losses suffered or incurred by them as a result of any patent, copyright, or other intellectual property infringement or any other claim by any third party arising as result of the applicable agreement with the Company. The Company generally attempts to limit the maximum amount of indemnification that the Company could be required to make under these agreements, to the amount of fees received by the Company. |
Equity_Incentive_Plans_and_Sto
Equity Incentive Plans and Stock-Based Compensation | 3 Months Ended | ||||||||||||
Mar. 31, 2014 | |||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | ||||||||||||
Equity Incentive Plans and Stock-Based Compensation | ' | ||||||||||||
Equity Incentive Plans and Stock-Based Compensation | |||||||||||||
As of March 31, 2014, 700,058 shares of the 21,400,000 shares approved under the 2006 Equity Incentive Plan (the “2006 Plan”) remain available for grant which included an increase of 6,500,000 shares approved by stockholders on April 26, 2012. The 2006 Plan is now the Company’s only plan for providing stock-based incentive awards to eligible employees, executive officers, non-employee directors and consultants; however, the 1997 Stock Option Plan (the “1997 Plan”) will continue to govern awards previously granted under that plan. | |||||||||||||
A summary of shares available for grant under the Company’s plans is as follows: | |||||||||||||
Shares Available | |||||||||||||
for Grant | |||||||||||||
Shares available as of December 31, 2013 | 2,527,428 | ||||||||||||
Stock options granted | (1,797,462 | ) | |||||||||||
Stock options forfeited | 269,083 | ||||||||||||
Stock options expired under former plans | (9,900 | ) | |||||||||||
Nonvested equity stock and stock units granted (1) | (308,712 | ) | |||||||||||
Nonvested equity stock and stock units forfeited (1) | 19,621 | ||||||||||||
Total available for grant as of March 31, 2014 | 700,058 | ||||||||||||
_________________________________________ | |||||||||||||
-1 | For purposes of determining the number of shares available for grant under the 2006 Plan against the maximum number of shares authorized, each share of restricted stock granted reduces the number of shares available for grant by 1.5 shares and each share of restricted stock forfeited increases shares available for grant by 1.5 shares. | ||||||||||||
General Stock Option Information | |||||||||||||
The following table summarizes stock option activity under the 1997 Plan and 2006 Plan for the three months ended March 31, 2014 and information regarding stock options outstanding, exercisable, and vested and expected to vest as of March 31, 2014. | |||||||||||||
Options Outstanding | |||||||||||||
Number of | Weighted | Weighted | Aggregate | ||||||||||
Shares | Average | Average | Intrinsic | ||||||||||
Exercise Price | Remaining | Value | |||||||||||
Per Share | Contractual | ||||||||||||
Term (years) | |||||||||||||
(In thousands, except per share amounts) | |||||||||||||
Outstanding as of December 31, 2013 | 11,377,146 | $ | 11.32 | ||||||||||
Options granted | 1,797,462 | $ | 8.78 | ||||||||||
Options exercised | (206,843 | ) | $ | 6.73 | |||||||||
Options forfeited | (269,083 | ) | $ | 15.2 | |||||||||
Outstanding as of March 31, 2014 | 12,698,682 | $ | 10.95 | 6.13 | $ | 36,153 | |||||||
Vested or expected to vest at March 31, 2014 | 11,752,766 | $ | 11.25 | 5.91 | $ | 32,643 | |||||||
Options exercisable at March 31, 2014 | 6,303,547 | $ | 14.94 | 3.74 | $ | 10,850 | |||||||
No stock options that contain a market condition were granted during the three months ended March 31, 2014. The fair values of the options granted with a market condition were calculated using a binomial valuation model, which estimates the potential outcome of reaching the market condition based on simulated future stock prices. As of both March 31, 2014 and December 31, 2013, there were 1,315,000 stock options outstanding that require the Company to achieve minimum market conditions in order for the options to become exercisable. | |||||||||||||
The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value for in-the-money options at March 31, 2014, based on the $10.75 closing stock price of Rambus’ common stock on March 31, 2014 on the NASDAQ Global Select Market, which would have been received by the option holders had all option holders exercised their options as of that date. The total number of in-the-money options outstanding and exercisable as of March 31, 2014 was 8,833,026 and 2,656,578, respectively. | |||||||||||||
Employee Stock Purchase Plan | |||||||||||||
No purchases were made under the 2006 Employee Stock Purchase Plan (“ESPP”) during the three months ended March 31, 2014 and 2013, respectively. As of March 31, 2014, 19,232 shares under the ESPP remain available for issuance. On September 27, 2013, the Company filed a Registration Statement on Form S-8, registering 1,500,000 additional shares under the ESPP in connection with the commencement of the next subscription period under the ESPP. On April 24, 2014, the Company held its 2014 Annual Meeting of Stockholders where an amendment to the ESPP to increase the number of shares of common stock reserved for issuance under the ESPP by 1,500,000 shares was approved. | |||||||||||||
Stock-Based Compensation | |||||||||||||
For the three months ended March 31, 2014 and 2013, the Company maintained stock plans covering a broad range of potential equity grants including stock options, nonvested equity stock and equity stock units and performance based instruments. In addition, the Company sponsors an ESPP, whereby eligible employees are entitled to purchase common stock semi-annually, by means of limited payroll deductions, at a 15% discount from the fair market value of the common stock as of specific dates. | |||||||||||||
Stock Options | |||||||||||||
During the three months ended March 31, 2014 and 2013, the Company granted 1,797,462 and 1,619,437 stock options, respectively, with an estimated total grant-date fair value of $7.0 million and $3.8 million, respectively. During the three months ended March 31, 2014 and 2013, the Company recorded stock-based compensation expense related to stock options of $2.2 million and $3.1 million, respectively. | |||||||||||||
As of March 31, 2014, there was $19.4 million of total unrecognized compensation cost, net of expected forfeitures, related to non-vested stock-based compensation arrangements granted under the stock option plans. That cost is expected to be recognized over a weighted-average period of 2.5 years. The total fair value of shares vested as of March 31, 2014 was $63.4 million. | |||||||||||||
The total intrinsic value of options exercised was $0.6 million for the three months ended March 31, 2014. There were no options exercised during the three months ended March 31, 2013. Intrinsic value is the total value of exercised shares based on the price of the Company’s common stock at the time of exercise less the cash received from the employees to exercise the options. | |||||||||||||
During the three months ended March 31, 2014, net proceeds from employee stock option exercises totaled approximately $1.4 million. | |||||||||||||
Employee Stock Purchase Plan | |||||||||||||
For the three months ended March 31, 2014, the Company recorded an immaterial amount of compensation expense related to the ESPP. For the three months ended March 31, 2013, the Company recorded compensation expense related to the ESPP of $0.5 million. As of March 31, 2014, there was an immaterial amount of total unrecognized compensation cost related to stock-based compensation arrangements granted under the ESPP. That cost is expected to be recognized over one month. | |||||||||||||
There were no tax benefits realized as a result of employee stock option exercises, stock purchase plan purchases, and vesting of equity stock and stock units for the three months ended March 31, 2014 and 2013 calculated in accordance with accounting for share-based payments. | |||||||||||||
Valuation Assumptions | |||||||||||||
The fair value of stock awards is estimated as of the grant date using the Black-Scholes-Merton (“BSM”) option-pricing model assuming a dividend yield of 0% and the additional weighted-average assumptions as listed in the table below. | |||||||||||||
The following table presents the weighted-average assumptions used to estimate the fair value of stock options granted that contain only service conditions in the periods presented. | |||||||||||||
Stock Option Plans | |||||||||||||
Three Months Ended | |||||||||||||
March 31, | |||||||||||||
2014 | 2013 | ||||||||||||
Stock Option Plans | |||||||||||||
Expected stock price volatility | 44 | % | 47 | % | |||||||||
Risk free interest rate | 2.1 | % | 0.9 | % | |||||||||
Expected term (in years) | 6.1 | 5.4 | |||||||||||
Weighted-average fair value of stock options granted to employees | $ | 3.92 | $ | 2.33 | |||||||||
No shares were issued under the Employee Stock Purchase Plan during the three months ended March 31, 2014 and 2013. | |||||||||||||
Nonvested Equity Stock and Stock Units | |||||||||||||
The Company grants nonvested equity stock units to officers, employees and directors. During the three months ended March 31, 2014, the Company granted nonvested equity stock units totaling 205,808 shares under the 2006 Plan. During the three months ended March 31, 2013, the Company granted nonvested equity stock units totaling 276,496 under the 2006 Plan. These awards have a service condition, generally a service period of four years, except in the case of grants to directors, for which the service period is one year. For the three months ended March 31, 2014, the nonvested equity stock units were valued at the date of grant giving them a fair value of approximately $1.8 million. For the three months ended March 31, 2013, the nonvested equity stock units were valued at the date of grant giving them a fair value of approximately $1.5 million. In prior years, the Company granted nonvested equity stock units to its employees with vesting subject to the achievement of certain performance conditions. During the three months ended March 31, 2014, the Company did not record any stock-based compensation expense related to these performance stock units as they have been forfeited. During the three months ended March 31, 2013, the achievement of certain performance conditions for certain performance equity stock units was considered probable, and as a result, the Company recognized an immaterial amount of stock-based compensation expense related to these performance stock units for this period. | |||||||||||||
For the three months ended March 31, 2014, the Company recorded stock-based compensation expense of approximately $0.7 million related to all outstanding unvested equity stock grants. For the three months ended March 31, 2013, the Company recorded stock-based compensation expense of approximately $1.3 million related to all outstanding unvested equity stock grants. Unrecognized stock-based compensation related to all nonvested equity stock grants, net of estimated forfeitures, was approximately $4.3 million at March 31, 2014. This amount is expected to be recognized over a weighted average period of 2.6 years. | |||||||||||||
The following table reflects the activity related to nonvested equity stock and stock units for the three months ended March 31, 2014: | |||||||||||||
Nonvested Equity Stock and Stock Units | Shares | Weighted- | |||||||||||
Average | |||||||||||||
Grant-Date | |||||||||||||
Fair Value | |||||||||||||
Nonvested at December 31, 2013 | 629,649 | $ | 8.56 | ||||||||||
Granted | 205,808 | $ | 8.79 | ||||||||||
Vested | (117,828 | ) | $ | 9.56 | |||||||||
Forfeited | (13,078 | ) | $ | 6.67 | |||||||||
Nonvested at March 31, 2014 | 704,551 | $ | 8.49 | ||||||||||
Stockholders_Equity
Stockholders' Equity | 3 Months Ended |
Mar. 31, 2014 | |
Stockholders' Equity Note [Abstract] | ' |
Stockholders' Equity | ' |
Stockholders’ Equity | |
Share Repurchase Program | |
During the three months ended March 31, 2014, the Company did not repurchase any shares of its common stock under its share repurchase program. As of March 31, 2014, the Company had repurchased a cumulative total of approximately 26.3 million shares of its common stock with an aggregate price of approximately $428.9 million since the commencement of the program in 2001. As of March 31, 2014, there remained an outstanding authorization to repurchase approximately 5.2 million shares of the Company’s outstanding common stock. | |
The Company records stock repurchases as a reduction to stockholders’ equity. The Company records a portion of the purchase price of the repurchased shares as an increase to accumulated deficit when the price of the shares repurchased exceeds the average original proceeds per share received from the issuance of common stock. |
Restructuring_Charges
Restructuring Charges | 3 Months Ended | ||||||||||||
Mar. 31, 2014 | |||||||||||||
Restructuring Charges [Abstract] | ' | ||||||||||||
Restructuring Charges | ' | ||||||||||||
Restructuring Charges | |||||||||||||
The 2013 Plan | |||||||||||||
During 2013, the Company initiated a restructuring program related primarily to its LDT group as a result of the change in its business strategy to reduce its focus on the lower margin bulb products. Additionally, the Company curtailed its immersive media platform spending (the “2013 Plan”). In connection with this restructuring program, the Company estimated that it would incur aggregate costs of approximately $3.0 million to $4.0 million. During the three months ended March 31, 2014, the Company incurred an immaterial amount of restructuring charges related primarily to the reduction in workforce, which was related to the CTO reportable segment. The Company expects to substantially complete its restructuring activities related to this plan by the end of 2014. | |||||||||||||
The following table summarizes the 2013 Plan restructuring activities during the three months ended March 31, 2014: | |||||||||||||
Employee | Facilities | Total | |||||||||||
Severance | |||||||||||||
and Related Benefits | |||||||||||||
(In thousands) | |||||||||||||
Balance at December 31, 2013 | $ | 1,732 | $ | 133 | $ | 1,865 | |||||||
Charges | 39 | — | 39 | ||||||||||
Payments | (1,613 | ) | (133 | ) | (1,746 | ) | |||||||
Balance at March 31, 2014 | $ | 158 | $ | — | $ | 158 | |||||||
Income_Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2014 | |
Income Tax Disclosure [Abstract] | ' |
Income Taxes | ' |
Income Taxes | |
The Company recorded a provision for income taxes of $5.5 million and $4.5 million for the three months ended March 31, 2014 and 2013, respectively. The provision for income taxes for the three months ended March 31, 2014 and 2013 is primarily comprised of withholding taxes, state taxes and other foreign taxes based upon income earned during the period. | |
During the three months ended March 31, 2014 and 2013, the Company paid withholding taxes of $5.1 million and $3.8 million, respectively. | |
As of March 31, 2014, the Company’s condensed consolidated balance sheets included net deferred tax assets, before valuation allowance, of approximately $188.7 million, which consists of net operating loss carryovers, tax credit carryovers, amortization, employee stock-based compensation expenses and certain liabilities, partially reduced by deferred tax liabilities associated with the convertible debt instruments. As of March 31, 2014, a full valuation allowance has been recorded against the U.S. deferred tax assets. The Company’s deferred tax assets decrease during the three months ended March 31, 2014 is primarily due to the utilization of U.S. tax attribute carryforward. | |
Management periodically evaluates the realizability of the Company's net deferred tax assets based on all available evidence, both positive and negative. The realization of net deferred tax assets is dependent on the Company's ability to generate sufficient future taxable income during periods prior to the expiration of tax attributes to fully utilize these assets. The Company weighed both positive and negative evidence and determined that there is a continued need for a valuation allowance as the Company is in a cumulative loss position over the previous three years, which is considered significant negative evidence. A sustained period of profitability in the Company's operations is required before the Company would change its judgment regarding the need for a full valuation allowance against its net deferred tax assets. Although the weight of negative evidence related to cumulative losses has decreased as the Company has settled outstanding litigation, the Company believes that this objectively measured negative evidence outweighs the subjectively determined positive evidence of future profitability and, as such, the Company has not changed its judgment regarding the need for a full valuation allowance on its deferred tax assets in the United States as of March 31, 2014. However, continued improvement in the Company's operating results, conditioned on its MID, LDT or CRI reporting units successfully commercializing new business arrangements, signing new or renewing existing license agreements and managing costs, could lead to reversal of almost all of the Company's valuation allowance as early as the remainder of 2014. Until such time, consumption of tax attributes to offset profits will reduce the overall level of deferred tax assets subject to valuation allowance. Should the Company determine that it would be able to realize its remaining deferred tax assets in the foreseeable future, an adjustment to its remaining deferred tax assets would cause a material increase to income in the period such determination is made. | |
The Company maintains liabilities for uncertain tax positions within its long-term income taxes payable accounts and as a reduction to existing deferred tax assets to the extent tax attributes are available to offset such liabilities. These liabilities involve judgment and estimation and are monitored by management based on the best information available including changes in tax regulations, the outcome of relevant court cases and other information. | |
As of March 31, 2014, the Company had approximately $20.0 million of unrecognized tax benefits, including $18.0 million recorded as a reduction of long-term deferred tax assets and $2.0 million in long-term income taxes payable. If recognized, approximately $2.0 million would be recorded as an income tax benefit. No benefit would be recorded for the remaining unrecognized tax benefits as the recognition would require a corresponding increase in the valuation allowance. As of December 31, 2013, the Company had $18.8 million of unrecognized tax benefits, including $12.6 million recorded as a reduction of long-term deferred tax assets and $6.2 million recorded in long-term income taxes payable. | |
Although it is possible that some of the unrecognized tax benefits could be settled within the next 12 months, the Company cannot reasonably estimate the outcome at this time. | |
The Company recognizes interest and penalties related to uncertain tax positions as a component of the income tax provision. At March 31, 2014 and December 31, 2013, an immaterial amount of interest and penalties is included in long-term income taxes payable. | |
Rambus files income tax returns for the U.S., California, India and various other state and foreign jurisdictions. The U.S. federal returns are subject to examination from 2012 and forward. The California returns are subject to examination from 2009 and forward. In addition, any research and development credit carryforward or net operating loss carryforward generated in prior years and utilized in these or future years may also be subject to examination. The India returns are subject to examination from fiscal year ending March 2006 and forward. The Company is currently under examination by California for the 2010 and 2011 tax years and by India for fiscal years ending March 2006, 2009 and 2010. Management regularly assesses the likelihood of outcomes resulting from income tax examinations to determine the adequacy of their provision for income taxes and believes their provision for unrecognized tax benefits is adequate. In January 2014, an Internal Revenue Service examination covering the 2010 through 2011 tax years was completed with no audit adjustments. | |
Additionally, the Company's future effective tax rates could be adversely affected by earnings being higher than anticipated in countries where the Company has higher statutory rates or lower than anticipated in countries where it has lower statutory rates, by changes in valuation of its deferred tax assets and liabilities or by changes in tax laws or interpretations of those laws. |
Litigation_and_Asserted_Claims
Litigation and Asserted Claims | 3 Months Ended |
Mar. 31, 2014 | |
LitigationAndAssertedClaimsDisclosureAbstract | ' |
Litigation and Asserted Claims | ' |
Litigation and Asserted Claims | |
SDRAM, DDR, DDR2, DDR3, gDDR2, GDDR3, GDDR4 Litigation (“DDR2”) | |
U.S District Court in the Northern District of California | |
On January 25, 2005, Rambus filed a patent infringement suit in the U.S. District Court for the Northern District of California against SK hynix, Infineon, Nanya, and Inotera. On January 13, 2006, Rambus also filed suit against Micron in the same court for patent infringement. Infineon and Inotera were subsequently dismissed from this litigation as was Samsung, which previously had been added as a defendant. Rambus alleged that certain of its patents were infringed by certain of the defendants' DDR2 and other advanced memory products. On June 11, 2013, Rambus and SK hynix announced that they had entered into a settlement of all outstanding disputes between the parties and on December 9, 2013, Rambus and Micron announced that they had entered into a settlement of all outstanding disputes between the parties, which is described in Note 15, "Agreements with SK hynix and Micron. On March 23, 2014, Rambus and Nanya announced that they had entered into a settlement of all outstanding disputes between the parties. As a result of such settlements, all DDR2 litigation has been dismissed. | |
Potential Future Litigation | |
In addition to the litigation described above, companies continue to adopt Rambus technologies into various products. Rambus has notified many of these companies of their use of Rambus technology and continues to evaluate how to proceed on these matters. In the ordinary course of business, Rambus may also be involved in other various legal proceedings and claims related to commercial, corporate and securities, labor and employment, wage and hour, and other types of claims. There can be no assurance that any future litigation will be successful or resolved favorably to the Company. The outcome of any litigation, as well as any delay in its resolution, is inherently uncertain and could adversely affect Rambus' ability to license its intellectual property in the future. | |
The Company records a contingent liability when it is probable that a loss has been incurred and the amount is reasonably estimable in accordance with accounting for contingencies. |
Agreement_with_SK_hynix_and_Mi
Agreement with SK hynix and Micron | 3 Months Ended | |||||||||||||||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||||||||||||||
Patent License Agreement [Abstract] | ' | |||||||||||||||||||||||||||||||
Agreement with SK hynix and Micron | ' | |||||||||||||||||||||||||||||||
Agreements with SK hynix and Micron | ||||||||||||||||||||||||||||||||
SK hynix | ||||||||||||||||||||||||||||||||
On June 11, 2013, Rambus, SK hynix and certain related entities of SK hynix entered into a settlement agreement, pursuant to which the parties have agreed to release all claims against each other with respect to all outstanding litigation between them. Pursuant to the settlement agreement, Rambus and SK hynix entered into a semiconductor patent license agreement on June 11, 2013, under which SK hynix licenses from Rambus non-exclusive rights to certain Rambus patents and has agreed to pay Rambus cash amounts over the next five years. Under the license agreement, Rambus has granted to SK hynix (i) a paid-up perpetual patent license for certain identified SK hynix DRAM products and (ii) a five-year term patent license to all other DRAM and other semiconductor products. | ||||||||||||||||||||||||||||||||
The agreements with SK hynix are considered a multiple element arrangement for accounting purposes. For a multiple element arrangement under the applicable accounting rules, the Company is required to identify specific elements of the arrangement and then determine when those elements should be recognized. The Company identified three elements in the arrangement: antitrust litigation settlement, settlement of past infringement, and license agreement. The Company considered several factors in determining the accounting fair value of the elements of the SK hynix agreements which included a third party valuation using an income approach (collectively the “SK hynix Fair Value”). The inputs and assumptions used in this accounting valuation were from a market participant perspective and included projected customer revenue, royalty rates, estimated discount rates, useful lives and income tax rates, among others. The development of a number of these inputs and assumptions in the model requires a significant amount of management judgment and discretion, and is based upon a number of factors, including the selection of industry comparables, market growth rates and other relevant factors. Changes in any number of these assumptions may have a substantial impact on the SK hynix Fair Value as assigned to each element. These inputs and assumptions represent management’s best estimates at the time of the transaction. | ||||||||||||||||||||||||||||||||
During the first quarter of 2014, the Company received cash consideration of $12.0 million from SK hynix. The amount was allocated between royalty revenue ($11.8 million) and gain from settlement ($0.2 million) based on the elements’ SK hynix Fair Value. | ||||||||||||||||||||||||||||||||
The remaining $204.0 million is expected to be paid in successive quarterly payments of $12.0 million, concluding in the second quarter of 2018. | ||||||||||||||||||||||||||||||||
The cumulative cash receipts through March 31, 2014 and the remaining future cash receipts from the agreements with SK hynix are expected to be recognized as follows assuming no adjustments to the payments under the terms of the agreements: | ||||||||||||||||||||||||||||||||
Cumulative Received | Estimated to Be Received in | Total Estimated | ||||||||||||||||||||||||||||||
to-date as of March 31, | Cash Receipts | |||||||||||||||||||||||||||||||
2014 | Remainder | 2015 | 2016 | 2017 | 2018 | |||||||||||||||||||||||||||
of 2014 | ||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Royalty revenue | $ | 35.4 | $ | 35.5 | $ | 47.3 | $ | 47.9 | $ | 48 | $ | 24 | $ | 238.1 | ||||||||||||||||||
Gain from settlement | 0.6 | 0.5 | 0.7 | 0.1 | — | — | 1.9 | |||||||||||||||||||||||||
Total | $ | 36 | $ | 36 | $ | 48 | $ | 48 | $ | 48 | $ | 24 | $ | 240 | ||||||||||||||||||
Micron | ||||||||||||||||||||||||||||||||
On December 9, 2013, Rambus, Micron and certain related entities of Micron entered into a settlement agreement, pursuant to which the parties have agreed that they will release all claims against each other with respect to all outstanding litigation between them and certain other potential claims. Pursuant to the settlement agreement, Rambus and Micron entered into a semiconductor patent license agreement on December 9, 2013. Under the license agreement, Rambus has granted to Micron and its subsidiaries and certain affiliated entities (i) a paid-up perpetual patent license for certain identified Micron DRAM products and (ii) a seven-year term patent license to other memory and semiconductor products. | ||||||||||||||||||||||||||||||||
The agreements with Micron are considered a multiple element arrangement for accounting purposes. For a multiple element arrangement under the applicable accounting rules, the Company is required to identify specific elements of the arrangement and then determine when those elements should be recognized. The Company identified three elements in the arrangement: antitrust litigation settlement, settlement of past infringement, and license agreement. The Company considered several factors in determining the accounting fair value of the elements of the Micron agreements which included a third party valuation using an income approach (collectively the “Micron Fair Value”). The inputs and assumptions used in this accounting valuation were from a market participant perspective and included projected customer revenue, royalty rates, estimated discount rates, useful lives and income tax rates, among others. The development of a number of these inputs and assumptions in the model requires a significant amount of management judgment and discretion, and is based upon a number of factors, including the selection of industry comparables, market growth rates and other relevant factors. Changes in any number of these assumptions may have a substantial impact on the Micron Fair Value as assigned to each element. These inputs and assumptions represent management’s best estimates at the time of the transaction. | ||||||||||||||||||||||||||||||||
During the first quarter of 2014, the Company received cash consideration of $10.0 million from Micron. The amount was allocated between royalty revenue ($9.7 million) and gain from settlement ($0.3 million) based on the elements’ Micron Fair Value. | ||||||||||||||||||||||||||||||||
The remaining $264.5 million is expected to be paid in successive quarterly payments of $10.0 million, concluding in the fourth quarter of 2020. | ||||||||||||||||||||||||||||||||
The cumulative cash receipts through March 31, 2014 and the remaining future cash receipts from the agreements with Micron are expected to be recognized as follows assuming no adjustments to the payments under the terms of the agreements: | ||||||||||||||||||||||||||||||||
Cumulative Received | Estimated to Be Received in | Total Estimated | ||||||||||||||||||||||||||||||
to-date as of March 31, | Cash Receipts | |||||||||||||||||||||||||||||||
2014 | Remainder of 2014 | 2015 | 2016 | 2017 | 2018 | 2019 and thereafter | ||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Royalty revenue | $ | 15 | $ | 29 | $ | 38.7 | $ | 39.5 | $ | 40 | $ | 40 | $ | 74.5 | $ | 276.7 | ||||||||||||||||
Gain from settlement | 0.5 | 1 | 1.3 | 0.5 | — | — | — | 3.3 | ||||||||||||||||||||||||
Total | $ | 15.5 | $ | 30 | $ | 40 | $ | 40 | $ | 40 | $ | 40 | $ | 74.5 | $ | 280 | ||||||||||||||||
Earnings_Loss_Per_Share_Tables
Earnings (Loss) Per Share (Tables) | 3 Months Ended | ||||||||
Mar. 31, 2014 | |||||||||
Earnings Per Share [Abstract] | ' | ||||||||
Computation of basic and diluted loss per share | ' | ||||||||
The following table sets forth the computation of basic and diluted net income (loss) per share: | |||||||||
Three Months Ended March 31, | |||||||||
2014 | 2013 | ||||||||
Net income (loss) per share: | (In thousands, except per share amounts) | ||||||||
Numerator: | |||||||||
Net income (loss) | $ | 7,804 | $ | (10,402 | ) | ||||
Denominator: | |||||||||
Weighted-average shares outstanding - basic | 113,590 | 111,599 | |||||||
Effect of potential dilutive common shares | 3,039 | — | |||||||
Weighted-average shares outstanding - diluted | 116,629 | 111,599 | |||||||
Basic net income (loss) per share | $ | 0.07 | $ | (0.09 | ) | ||||
Diluted net income (loss) per share | $ | 0.07 | $ | (0.09 | ) | ||||
Intangible_Asset_and_Goodwill_
Intangible Asset and Goodwill (Tables) | 3 Months Ended | ||||||||||||||||
Mar. 31, 2014 | |||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | ||||||||||||||||
Schedule of changes in carrying amount of goodwill by reporting unit | ' | ||||||||||||||||
The following tables present goodwill information for each of the reportable segments for the three months ended March 31, 2014: | |||||||||||||||||
Reportable Segment: | December 31, | Additions to Goodwill | Impairment Charge of Goodwill | March 31, | |||||||||||||
2013 | 2014 | ||||||||||||||||
(In thousands) | |||||||||||||||||
MID | $ | 19,905 | $ | — | $ | — | $ | 19,905 | |||||||||
CTO | — | — | — | — | |||||||||||||
CRI | 96,994 | — | — | 96,994 | |||||||||||||
Other | — | — | — | — | |||||||||||||
Total | $ | 116,899 | $ | — | $ | — | $ | 116,899 | |||||||||
As of | |||||||||||||||||
March 31, 2014 | |||||||||||||||||
Reportable Segment: | Gross Carrying Amount | Accumulated Impairment Losses | Net Carrying Amount | ||||||||||||||
(In thousands) | |||||||||||||||||
MID | $ | 19,905 | $ | — | $ | 19,905 | |||||||||||
CTO | 8,070 | (8,070 | ) | — | |||||||||||||
CRI | 96,994 | — | 96,994 | ||||||||||||||
Other | 13,700 | (13,700 | ) | — | |||||||||||||
Total | $ | 138,669 | $ | (21,770 | ) | $ | 116,899 | ||||||||||
Components of intangible assets | ' | ||||||||||||||||
The components of the Company’s intangible assets as of March 31, 2014 and December 31, 2013 were as follows: | |||||||||||||||||
As of March 31, 2014 | |||||||||||||||||
Useful Life | Gross Carrying | Accumulated | Net Carrying | ||||||||||||||
Amount | Amortization | Amount | |||||||||||||||
(In thousands) | |||||||||||||||||
Existing technology | 3 to 10 years | $ | 185,321 | $ | (86,476 | ) | $ | 98,845 | |||||||||
Customer contracts and contractual relationships | 1 to 10 years | 31,093 | (20,695 | ) | 10,398 | ||||||||||||
Non-compete agreements | 3 years | 300 | (283 | ) | 17 | ||||||||||||
Total intangible assets | $ | 216,714 | $ | (107,454 | ) | $ | 109,260 | ||||||||||
As of December 31, 2013 | |||||||||||||||||
Useful Life | Gross Carrying | Accumulated | Net Carrying | ||||||||||||||
Amount | Amortization | Amount | |||||||||||||||
(In thousands) | |||||||||||||||||
Existing technology | 3 to 10 years | $ | 186,202 | $ | (80,961 | ) | $ | 105,241 | |||||||||
Customer contracts and contractual relationships | 1 to 10 years | 31,093 | (19,204 | ) | 11,889 | ||||||||||||
Non-compete agreements | 3 years | 300 | (258 | ) | 42 | ||||||||||||
Total intangible assets | $ | 217,595 | $ | (100,423 | ) | $ | 117,172 | ||||||||||
Estimated future amortization expense of intangible assets | ' | ||||||||||||||||
The estimated future amortization expense of intangible assets as of March 31, 2014 was as follows (amounts in thousands): | |||||||||||||||||
Years Ending December 31: | Amount | ||||||||||||||||
2014 (remaining 9 months) | $ | 19,846 | |||||||||||||||
2015 | 25,098 | ||||||||||||||||
2016 | 24,335 | ||||||||||||||||
2017 | 23,734 | ||||||||||||||||
2018 | 10,827 | ||||||||||||||||
Thereafter | 5,420 | ||||||||||||||||
$ | 109,260 | ||||||||||||||||
Segments_and_Major_Customers_T
Segments and Major Customers (Tables) | 3 Months Ended | |||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||||||
Reported segment revenues, and reported segment direct operating income (loss) | ' | |||||||||||||||||||
The tables below present reported segment operating income (loss) for the three months ended March 31, 2014 and 2013, respectively. | ||||||||||||||||||||
For the Three Months Ended March 31, 2014 | ||||||||||||||||||||
MID | CRI | CTO | Other | Total | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
Revenues | $ | 61,156 | $ | 12,903 | $ | — | $ | 4,229 | $ | 78,288 | ||||||||||
Segment operating expenses | 9,920 | 7,629 | 4,271 | 4,382 | 26,202 | |||||||||||||||
Segment operating income (loss) | $ | 51,236 | $ | 5,274 | $ | (4,271 | ) | $ | (153 | ) | $ | 52,086 | ||||||||
Reconciling items | (28,897 | ) | ||||||||||||||||||
Operating income | $ | 23,189 | ||||||||||||||||||
Interest and other income (expense), net | (9,913 | ) | ||||||||||||||||||
Income before income taxes | $ | 13,276 | ||||||||||||||||||
For the Three Months Ended March 31, 2013 | ||||||||||||||||||||
MID | CRI | CTO | Other | Total | ||||||||||||||||
(In thousands) | ||||||||||||||||||||
Revenues | $ | 59,674 | $ | 6,883 | $ | — | $ | 309 | $ | 66,866 | ||||||||||
Segment operating expenses | 9,884 | 4,888 | 7,171 | 3,629 | 25,572 | |||||||||||||||
Segment operating income (loss) | $ | 49,790 | $ | 1,995 | $ | (7,171 | ) | $ | (3,320 | ) | $ | 41,294 | ||||||||
Reconciling items | (39,853 | ) | ||||||||||||||||||
Operating income | $ | 1,441 | ||||||||||||||||||
Interest and other income (expense), net | (7,332 | ) | ||||||||||||||||||
Loss before income taxes | $ | (5,891 | ) | |||||||||||||||||
Schedule of customer accounts representing 10% or more than 10% of total revenue | ' | |||||||||||||||||||
Revenue from the Company’s major customers representing 10% or more of total revenue for the three months ended March 31, 2014 and 2013, respectively, was as follows: | ||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||
March 31, | ||||||||||||||||||||
Customer | 2014 | 2013 | ||||||||||||||||||
Customer A (MID and CRI reportable segments) | 19 | % | 33 | % | ||||||||||||||||
Customer B (MID reportable segment) | 15 | % | * | |||||||||||||||||
Customer C (MID reportable segment) | 12 | % | * | |||||||||||||||||
Customer D (MID reportable segment) | * | 15 | % | |||||||||||||||||
Customer E (MID reportable segment) | * | 10 | % | |||||||||||||||||
_________________________________________ | ||||||||||||||||||||
* Customer accounted for less than 10% of total revenue in the period | ||||||||||||||||||||
Revenue from external customer by geographic regions | ' | |||||||||||||||||||
Revenue from customers in the geographic regions based on the location of customers' headquarters is as follows: | ||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||
March 31, | ||||||||||||||||||||
(In thousands) | 2014 | 2013 | ||||||||||||||||||
South Korea | $ | 26,853 | $ | 22,025 | ||||||||||||||||
USA | 28,674 | 25,569 | ||||||||||||||||||
Japan | 9,255 | 14,609 | ||||||||||||||||||
Europe | 8,563 | 2,127 | ||||||||||||||||||
Canada | 1,824 | 1,786 | ||||||||||||||||||
Asia-Other | 3,119 | 750 | ||||||||||||||||||
Total | $ | 78,288 | $ | 66,866 | ||||||||||||||||
Marketable_Securities_Tables
Marketable Securities (Tables) | 3 Months Ended | |||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||
Available-for-sale Securities [Abstract] | ' | |||||||||||||||||||
Cash equivalents and marketable securities classified as available-for-sale | ' | |||||||||||||||||||
All cash equivalents and marketable securities are classified as available-for-sale. Total cash, cash equivalents and marketable securities are summarized as follows: | ||||||||||||||||||||
As of March 31, 2014 | ||||||||||||||||||||
(In thousands) | Fair Value | Amortized | Gross | Gross | Weighted | |||||||||||||||
Cost | Unrealized | Unrealized | Rate of | |||||||||||||||||
Gains | Losses | Return | ||||||||||||||||||
Money market funds | $ | 317,769 | $ | 317,769 | $ | — | $ | — | 0.01 | % | ||||||||||
Corporate notes, bonds and commercial paper | 58,347 | 58,355 | 1 | (9 | ) | 0.13 | % | |||||||||||||
Total cash equivalents and marketable securities | 376,116 | 376,124 | 1 | (9 | ) | |||||||||||||||
Cash | 27,308 | 27,308 | — | — | ||||||||||||||||
Total cash, cash equivalents and marketable securities | $ | 403,424 | $ | 403,432 | $ | 1 | $ | (9 | ) | |||||||||||
As of December 31, 2013 | ||||||||||||||||||||
(In thousands) | Fair Value | Amortized | Gross | Gross | Weighted | |||||||||||||||
Cost | Unrealized | Unrealized | Rate of | |||||||||||||||||
Gains | Losses | Return | ||||||||||||||||||
Money market funds | $ | 300,605 | $ | 300,605 | $ | — | $ | — | 0.01 | % | ||||||||||
Corporate notes, bonds and commercial paper | 58,492 | 58,507 | — | (15 | ) | 0.15 | % | |||||||||||||
Total cash equivalents and marketable securities | 359,097 | 359,112 | — | (15 | ) | |||||||||||||||
Cash | 28,565 | 28,565 | — | — | ||||||||||||||||
Total cash, cash equivalents and marketable securities | $ | 387,662 | $ | 387,677 | $ | — | $ | (15 | ) | |||||||||||
Available-for-sale securities reported at fair value | ' | |||||||||||||||||||
Available-for-sale securities are reported at fair value on the balance sheets and classified as follows: | ||||||||||||||||||||
As of | ||||||||||||||||||||
March 31, | December 31, | |||||||||||||||||||
2014 | 2013 | |||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Cash equivalents | $ | 319,268 | $ | 310,131 | ||||||||||||||||
Short term marketable securities | 56,848 | 48,966 | ||||||||||||||||||
Total cash equivalents and marketable securities | 376,116 | 359,097 | ||||||||||||||||||
Cash | 27,308 | 28,565 | ||||||||||||||||||
Total cash, cash equivalents and marketable securities | $ | 403,424 | $ | 387,662 | ||||||||||||||||
Estimated fair value of cash equivalents and marketable securities classified by the length of time that the securities have been in a continuous unrealized loss position | ' | |||||||||||||||||||
The estimated fair value of cash equivalents and marketable securities classified by the length of time that the securities have been in a continuous unrealized loss position at March 31, 2014 and December 31, 2013 are as follows: | ||||||||||||||||||||
Fair Value | Gross Unrealized Loss | |||||||||||||||||||
March 31, | December 31, | March 31, | December 31, | |||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||
(In thousands) | ||||||||||||||||||||
Less than one year | ||||||||||||||||||||
Corporate notes, bonds and commercial paper | $ | 43,151 | $ | 53,491 | $ | (9 | ) | $ | (15 | ) | ||||||||||
Fair_Value_of_Financial_Instru1
Fair Value of Financial Instruments (Tables) | 3 Months Ended | ||||||||||||||||||||||||
Mar. 31, 2014 | |||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ' | ||||||||||||||||||||||||
Summary of the valuation of cash equivalents and marketable securities by pricing levels | ' | ||||||||||||||||||||||||
The following table presents the financial instruments that are carried at fair value and summarizes the valuation of its cash equivalents and marketable securities by the above pricing levels as of March 31, 2014 and December 31, 2013: | |||||||||||||||||||||||||
As of March 31, 2014 | |||||||||||||||||||||||||
Total | Quoted | Significant | Significant | ||||||||||||||||||||||
Market | Other | Unobservable | |||||||||||||||||||||||
Prices in | Observable | Inputs | |||||||||||||||||||||||
Active | Inputs | (Level 3) | |||||||||||||||||||||||
Markets | (Level 2) | ||||||||||||||||||||||||
(Level 1) | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||
Money market funds | $ | 317,769 | $ | 317,769 | $ | — | $ | — | |||||||||||||||||
Corporate notes, bonds and commercial paper | 58,347 | — | 58,347 | — | |||||||||||||||||||||
Total available-for-sale securities | $ | 376,116 | $ | 317,769 | $ | 58,347 | $ | — | |||||||||||||||||
As of December 31, 2013 | |||||||||||||||||||||||||
Total | Quoted | Significant | Significant | ||||||||||||||||||||||
Market | Other | Unobservable | |||||||||||||||||||||||
Prices in | Observable | Inputs | |||||||||||||||||||||||
Active | Inputs | (Level 3) | |||||||||||||||||||||||
Markets | (Level 2) | ||||||||||||||||||||||||
(Level 1) | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||
Money market funds | $ | 300,605 | $ | 300,605 | $ | — | $ | — | |||||||||||||||||
Corporate notes, bonds and commercial paper | 58,492 | — | 58,492 | — | |||||||||||||||||||||
Total available-for-sale securities | $ | 359,097 | $ | 300,605 | $ | 58,492 | $ | — | |||||||||||||||||
Financial instruments that are measured and carried at cost on a nonrecurring basis | ' | ||||||||||||||||||||||||
The following table presents the financial instruments that are measured on a nonrecurring basis as of March 31, 2014: | |||||||||||||||||||||||||
As of March 31, 2014 | |||||||||||||||||||||||||
(in thousands) | Carrying Value | Quoted market prices in active markets (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Impairment charges for the three months ended March 31, 2014 | ||||||||||||||||||||
Investment in non-marketable securities | $ | 600 | $ | — | $ | — | $ | 600 | $ | — | |||||||||||||||
Financial instruments not carried at fair value but requiring fair value disclosure | ' | ||||||||||||||||||||||||
The following table presents the financial instruments that are not carried at fair value but require fair value disclosure as of March 31, 2014 and December 31, 2013: | |||||||||||||||||||||||||
As of March 31, 2014 | As of December 31, 2013 | ||||||||||||||||||||||||
(In thousands) | Face | Carrying | Fair Value | Face | Carrying | Fair Value | |||||||||||||||||||
Value | Value | Value | Value | ||||||||||||||||||||||
5% Convertible Senior Notes due 2014 (the "2014 Notes") | $ | 172,500 | $ | 168,658 | $ | 173,846 | $ | 172,500 | $ | 164,047 | $ | 175,821 | |||||||||||||
1.125% Convertible Senior Notes due 2018 (the "2018 Notes") | $ | 138,000 | $ | 110,962 | $ | 155,824 | $ | 138,000 | $ | 109,629 | $ | 142,427 | |||||||||||||
Convertible_Notes_Tables
Convertible Notes (Tables) | 3 Months Ended | ||||||||
Mar. 31, 2014 | |||||||||
Debt Disclosure [Abstract] | ' | ||||||||
Schedule of convertible notes | ' | ||||||||
The Company’s convertible notes are shown in the following table: | |||||||||
(In thousands) | As of March 31, 2014 | As of December 31, 2013 | |||||||
5% Convertible Senior Notes due 2014 | $ | 172,500 | $ | 172,500 | |||||
1.125% Convertible Senior Notes due 2018 | 138,000 | 138,000 | |||||||
Total principal amount of convertible notes | $ | 310,500 | $ | 310,500 | |||||
Unamortized discount - 2014 Notes | $ | (3,842 | ) | $ | (8,453 | ) | |||
Unamortized discount - 2018 Notes | (27,038 | ) | (28,371 | ) | |||||
Total unamortized discount | $ | (30,880 | ) | $ | (36,824 | ) | |||
Total convertible notes | $ | 279,620 | $ | 273,676 | |||||
Less current portion | 168,658 | 164,047 | |||||||
Total long-term convertible notes | $ | 110,962 | $ | 109,629 | |||||
Schedule of interest expense on notes | ' | ||||||||
Interest expense related to the notes for the three months ended March 31, 2014 and 2013 was as follows: | |||||||||
Three Months Ended | |||||||||
March 31, | |||||||||
2014 | 2013 | ||||||||
(In thousands) | |||||||||
2014 Notes coupon interest at a rate of 5% | $ | 2,156 | $ | 2,157 | |||||
2014 Notes amortization of discount and debt issuance costs at an additional effective interest rate of 11.7% | 4,769 | 4,089 | |||||||
2018 Notes coupon interest at a rate of 1.125% | 388 | — | |||||||
2018 Notes amortization of discount and debt issuance costs at an additional effective interest rate of 5.5% | 1,473 | — | |||||||
Total interest expense on convertible notes | $ | 8,786 | $ | 6,246 | |||||
Commitments_and_Contingencies_
Commitments and Contingencies (Tables) | 3 Months Ended | |||||||||||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | ' | |||||||||||||||||||||||||||
Company's material contractual obligations | ' | |||||||||||||||||||||||||||
As of March 31, 2014, the Company’s material contractual obligations were as follows (in thousands): | ||||||||||||||||||||||||||||
Total | Remainder of 2014 | 2015 | 2016 | 2017 | 2018 | Thereafter | ||||||||||||||||||||||
Contractual obligations (1) | ||||||||||||||||||||||||||||
Imputed financing obligation (2) | $ | 38,808 | $ | 4,422 | $ | 6,010 | $ | 6,156 | $ | 6,302 | $ | 6,447 | $ | 9,471 | ||||||||||||||
Leases and other contractual obligations | 7,118 | 2,399 | 2,118 | 1,243 | 1,018 | 340 | — | |||||||||||||||||||||
Software licenses (3) | 5,684 | 2,446 | 2,865 | 373 | — | — | — | |||||||||||||||||||||
Acquisition retention bonuses (4) | 16,749 | 16,679 | 70 | — | — | — | — | |||||||||||||||||||||
Convertible notes | 310,500 | 172,500 | — | — | — | 138,000 | — | |||||||||||||||||||||
Interest payments related to convertible notes | 11,300 | 5,089 | 1,553 | 1,553 | 1,553 | 1,552 | — | |||||||||||||||||||||
Total | $ | 390,159 | $ | 203,535 | $ | 12,616 | $ | 9,325 | $ | 8,873 | $ | 146,339 | $ | 9,471 | ||||||||||||||
_________________________________________ | ||||||||||||||||||||||||||||
-1 | The above table does not reflect possible payments in connection with uncertain tax benefits of approximately $20.0 million including $18.0 million recorded as a reduction of long-term deferred tax assets and $2.0 million in long-term income taxes payable as of March 31, 2014. As noted below in Note 13, “Income Taxes,” although it is possible that some of the unrecognized tax benefits could be settled within the next 12 months, the Company cannot reasonably estimate the outcome at this time. | |||||||||||||||||||||||||||
-2 | With respect to the imputed financing obligation, the main components of the difference between the amount reflected in the contractual obligations table and the amount reflected on the condensed consolidated balance sheets are the interest on the imputed financing obligation and the estimated common area expenses over the future periods. Additionally, the amount includes the amended Ohio lease and the amended Sunnyvale lease. | |||||||||||||||||||||||||||
-3 | The Company has commitments with various software vendors for non-cancellable license agreements generally having terms longer than one year. The above table summarizes those contractual obligations as of March 31, 2014 which are also presented on the Company’s condensed consolidated balance sheet under current and other long-term liabilities. | |||||||||||||||||||||||||||
-4 | In connection with acquisitions, the Company is obligated to pay retention bonuses to certain employees and contractors, subject to certain eligibility and acceleration provisions including the condition of employment. The remaining $16.7 million of CRI retention bonuses payable on June 3, 2014 can be paid in cash or stock at the Company’s election. |
Equity_Incentive_Plans_and_Sto1
Equity Incentive Plans and Stock-Based Compensation (Tables) | 3 Months Ended | ||||||||||||
Mar. 31, 2014 | |||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | ||||||||||||
Shares available for grant under stock-based incentive plans | ' | ||||||||||||
A summary of shares available for grant under the Company’s plans is as follows: | |||||||||||||
Shares Available | |||||||||||||
for Grant | |||||||||||||
Shares available as of December 31, 2013 | 2,527,428 | ||||||||||||
Stock options granted | (1,797,462 | ) | |||||||||||
Stock options forfeited | 269,083 | ||||||||||||
Stock options expired under former plans | (9,900 | ) | |||||||||||
Nonvested equity stock and stock units granted (1) | (308,712 | ) | |||||||||||
Nonvested equity stock and stock units forfeited (1) | 19,621 | ||||||||||||
Total available for grant as of March 31, 2014 | 700,058 | ||||||||||||
_________________________________________ | |||||||||||||
-1 | For purposes of determining the number of shares available for grant under the 2006 Plan against the maximum number of shares authorized, each share of restricted stock granted reduces the number of shares available for grant by 1.5 shares and each share of restricted stock forfeited increases shares available for grant by 1.5 shares. | ||||||||||||
Schedule of stock option activity | ' | ||||||||||||
The following table summarizes stock option activity under the 1997 Plan and 2006 Plan for the three months ended March 31, 2014 and information regarding stock options outstanding, exercisable, and vested and expected to vest as of March 31, 2014. | |||||||||||||
Options Outstanding | |||||||||||||
Number of | Weighted | Weighted | Aggregate | ||||||||||
Shares | Average | Average | Intrinsic | ||||||||||
Exercise Price | Remaining | Value | |||||||||||
Per Share | Contractual | ||||||||||||
Term (years) | |||||||||||||
(In thousands, except per share amounts) | |||||||||||||
Outstanding as of December 31, 2013 | 11,377,146 | $ | 11.32 | ||||||||||
Options granted | 1,797,462 | $ | 8.78 | ||||||||||
Options exercised | (206,843 | ) | $ | 6.73 | |||||||||
Options forfeited | (269,083 | ) | $ | 15.2 | |||||||||
Outstanding as of March 31, 2014 | 12,698,682 | $ | 10.95 | 6.13 | $ | 36,153 | |||||||
Vested or expected to vest at March 31, 2014 | 11,752,766 | $ | 11.25 | 5.91 | $ | 32,643 | |||||||
Options exercisable at March 31, 2014 | 6,303,547 | $ | 14.94 | 3.74 | $ | 10,850 | |||||||
Weighted-average assumptions for Stock Option Plans | ' | ||||||||||||
The following table presents the weighted-average assumptions used to estimate the fair value of stock options granted that contain only service conditions in the periods presented. | |||||||||||||
Stock Option Plans | |||||||||||||
Three Months Ended | |||||||||||||
March 31, | |||||||||||||
2014 | 2013 | ||||||||||||
Stock Option Plans | |||||||||||||
Expected stock price volatility | 44 | % | 47 | % | |||||||||
Risk free interest rate | 2.1 | % | 0.9 | % | |||||||||
Expected term (in years) | 6.1 | 5.4 | |||||||||||
Weighted-average fair value of stock options granted to employees | $ | 3.92 | $ | 2.33 | |||||||||
Schedule of nonvested equity stock and stock units activity | ' | ||||||||||||
The following table reflects the activity related to nonvested equity stock and stock units for the three months ended March 31, 2014: | |||||||||||||
Nonvested Equity Stock and Stock Units | Shares | Weighted- | |||||||||||
Average | |||||||||||||
Grant-Date | |||||||||||||
Fair Value | |||||||||||||
Nonvested at December 31, 2013 | 629,649 | $ | 8.56 | ||||||||||
Granted | 205,808 | $ | 8.79 | ||||||||||
Vested | (117,828 | ) | $ | 9.56 | |||||||||
Forfeited | (13,078 | ) | $ | 6.67 | |||||||||
Nonvested at March 31, 2014 | 704,551 | $ | 8.49 | ||||||||||
Restructuring_Charges_Tables
Restructuring Charges (Tables) | 3 Months Ended | ||||||||||||
Mar. 31, 2014 | |||||||||||||
Restructuring Charges [Abstract] | ' | ||||||||||||
Schedule of Restructuring and Related Costs | ' | ||||||||||||
The following table summarizes the 2013 Plan restructuring activities during the three months ended March 31, 2014: | |||||||||||||
Employee | Facilities | Total | |||||||||||
Severance | |||||||||||||
and Related Benefits | |||||||||||||
(In thousands) | |||||||||||||
Balance at December 31, 2013 | $ | 1,732 | $ | 133 | $ | 1,865 | |||||||
Charges | 39 | — | 39 | ||||||||||
Payments | (1,613 | ) | (133 | ) | (1,746 | ) | |||||||
Balance at March 31, 2014 | $ | 158 | $ | — | $ | 158 | |||||||
Agreement_with_SK_hynix_and_Mi1
Agreement with SK hynix and Micron (Tables) | 3 Months Ended | |||||||||||||||||||||||||||||||
Mar. 31, 2014 | ||||||||||||||||||||||||||||||||
Patent License Agreement [Abstract] | ' | |||||||||||||||||||||||||||||||
Schedule of cash receipts | ' | |||||||||||||||||||||||||||||||
The cumulative cash receipts through March 31, 2014 and the remaining future cash receipts from the agreements with SK hynix are expected to be recognized as follows assuming no adjustments to the payments under the terms of the agreements: | ||||||||||||||||||||||||||||||||
Cumulative Received | Estimated to Be Received in | Total Estimated | ||||||||||||||||||||||||||||||
to-date as of March 31, | Cash Receipts | |||||||||||||||||||||||||||||||
2014 | Remainder | 2015 | 2016 | 2017 | 2018 | |||||||||||||||||||||||||||
of 2014 | ||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Royalty revenue | $ | 35.4 | $ | 35.5 | $ | 47.3 | $ | 47.9 | $ | 48 | $ | 24 | $ | 238.1 | ||||||||||||||||||
Gain from settlement | 0.6 | 0.5 | 0.7 | 0.1 | — | — | 1.9 | |||||||||||||||||||||||||
Total | $ | 36 | $ | 36 | $ | 48 | $ | 48 | $ | 48 | $ | 24 | $ | 240 | ||||||||||||||||||
The cumulative cash receipts through March 31, 2014 and the remaining future cash receipts from the agreements with Micron are expected to be recognized as follows assuming no adjustments to the payments under the terms of the agreements: | ||||||||||||||||||||||||||||||||
Cumulative Received | Estimated to Be Received in | Total Estimated | ||||||||||||||||||||||||||||||
to-date as of March 31, | Cash Receipts | |||||||||||||||||||||||||||||||
2014 | Remainder of 2014 | 2015 | 2016 | 2017 | 2018 | 2019 and thereafter | ||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Royalty revenue | $ | 15 | $ | 29 | $ | 38.7 | $ | 39.5 | $ | 40 | $ | 40 | $ | 74.5 | $ | 276.7 | ||||||||||||||||
Gain from settlement | 0.5 | 1 | 1.3 | 0.5 | — | — | — | 3.3 | ||||||||||||||||||||||||
Total | $ | 15.5 | $ | 30 | $ | 40 | $ | 40 | $ | 40 | $ | 40 | $ | 74.5 | $ | 280 | ||||||||||||||||
Basis_of_Presentation_Details
Basis of Presentation (Details) | 3 Months Ended |
Mar. 31, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Percentage of ownership for cost method investment, maximum | 20.00% |
Recent_Accounting_Pronouncemen1
Recent Accounting Pronouncements ASU 2013-11 (Details) (USD $) | Mar. 31, 2014 |
In Millions, unless otherwise specified | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | ' |
Unrecognized Tax Benefits Resulting in Net Operating Loss Carryforward | $4.70 |
Earnings_Loss_Per_Share_Detail
Earnings (Loss) Per Share (Details) (USD $) | 3 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Numerator: | ' | ' |
Net Income (loss) | $7,804 | ($10,402) |
Denominator: | ' | ' |
Weighted-average common shares outstanding, Basic (in shares) | 113,590 | 111,599 |
Weighted Average Number Diluted Shares Outstanding Adjustment | 3,039 | 0 |
Denominator: | ' | ' |
Weighted-average common shares outstanding, Diluted (in shares) | 116,629 | 111,599 |
Earnings Per Share, Basic | $0.07 | ($0.09) |
Earnings Per Share, Diluted | $0.07 | ($0.09) |
Earnings_Loss_Per_Share_Detail1
Earnings (Loss) Per Share (Details 2) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Dilutive potential shares excluded from calculation of earnings per share due to the loss position | ' | ' |
Dilutive potential shares excluded from calculation of earnings per share due to the loss position | ' | 6.4 |
Options | ' | ' |
Anti-dilutive shares excluded from calculation of earnings per share | ' | ' |
Anti-dilutive shares excluded from calculation of earnigns per share | 6.9 | 12.9 |
Intangible_Asset_and_Goodwill_1
Intangible Asset and Goodwill (Details) (USD $) | 3 Months Ended |
In Thousands, unless otherwise specified | Mar. 31, 2014 |
Goodwill [Roll Forward] | ' |
Beginning Balance | $116,899 |
Additions to Goodwill | 0 |
Impairment Charge of Goodwill | 0 |
Ending Balance | 116,899 |
MID Segment | ' |
Goodwill [Roll Forward] | ' |
Beginning Balance | 19,905 |
Additions to Goodwill | 0 |
Impairment Charge of Goodwill | 0 |
Ending Balance | 19,905 |
CTO Segment | ' |
Goodwill [Roll Forward] | ' |
Beginning Balance | 0 |
Additions to Goodwill | 0 |
Impairment Charge of Goodwill | 0 |
Ending Balance | 0 |
CRI Segment | ' |
Goodwill [Roll Forward] | ' |
Beginning Balance | 96,994 |
Additions to Goodwill | 0 |
Impairment Charge of Goodwill | 0 |
Ending Balance | 96,994 |
Other | ' |
Goodwill [Roll Forward] | ' |
Beginning Balance | 0 |
Additions to Goodwill | 0 |
Impairment Charge of Goodwill | 0 |
Ending Balance | $0 |
Intangible_Asset_and_Goodwill_2
Intangible Asset and Goodwill (Details 2) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Goodwill | ' | ' |
Gross Carrying Amount | $138,669 | ' |
Accumulated Impairment Losses | -21,770 | ' |
Net Carrying Amount | 116,899 | 116,899 |
MID Segment | ' | ' |
Goodwill | ' | ' |
Gross Carrying Amount | 19,905 | ' |
Accumulated Impairment Losses | 0 | ' |
Net Carrying Amount | 19,905 | 19,905 |
CTO Segment | ' | ' |
Goodwill | ' | ' |
Gross Carrying Amount | 8,070 | ' |
Accumulated Impairment Losses | -8,070 | ' |
Net Carrying Amount | 0 | 0 |
CRI Segment | ' | ' |
Goodwill | ' | ' |
Gross Carrying Amount | 96,994 | ' |
Accumulated Impairment Losses | 0 | ' |
Net Carrying Amount | 96,994 | 96,994 |
Other | ' | ' |
Goodwill | ' | ' |
Gross Carrying Amount | 13,700 | ' |
Accumulated Impairment Losses | -13,700 | ' |
Net Carrying Amount | $0 | $0 |
Intangible_Asset_and_Goodwill_3
Intangible Asset and Goodwill (Details 3) (USD $) | 3 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | ||||||||
Mar. 31, 2014 | Mar. 31, 2013 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2013 | Dec. 31, 2013 | |
Existing technology | Existing technology | Existing technology | Existing technology | Existing technology | Existing technology | Customer contracts and contractual relationships | Customer contracts and contractual relationships | Customer contracts and contractual relationships | Customer contracts and contractual relationships | Customer contracts and contractual relationships | Customer contracts and contractual relationships | Non-compete agreements | Non-compete agreements | Favorable contracts | Favorable contracts | Favorable contracts | ||||
Minimum | Minimum | Maximum | Maximum | Minimum | Minimum | Maximum | Maximum | |||||||||||||
Components of intangible assets | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Useful Life (in years) | ' | ' | ' | ' | ' | '3 years | '3 years | '10 years | '10 years | ' | ' | '1 year | '1 year | '10 years | '10 years | '3 years | '3 years | ' | ' | ' |
Gross Carrying Amount | $216,714,000 | ' | $217,595,000 | $185,321,000 | $186,202,000 | ' | ' | ' | ' | $31,093,000 | $31,093,000 | ' | ' | ' | ' | $300,000 | $300,000 | ' | ' | ' |
Accumulated Amortization | -107,454,000 | ' | -100,423,000 | -86,476,000 | -80,961,000 | ' | ' | ' | ' | -20,695,000 | -19,204,000 | ' | ' | ' | ' | -283,000 | -258,000 | ' | ' | ' |
Net Carrying Amount | 109,260,000 | ' | 117,172,000 | 98,845,000 | 105,241,000 | ' | ' | ' | ' | 10,398,000 | 11,889,000 | ' | ' | ' | ' | 17,000 | 42,000 | 100,000 | ' | 1,000,000 |
Cash received related to favorable contracts | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 900,000 | 1,400,000 | ' |
Amortization expense for intangible assets | $6,797,000 | $7,040,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Intangible_Asset_and_Goodwill_4
Intangible Asset and Goodwill (Details 4) (USD $) | 3 Months Ended | |
Mar. 31, 2014 | Dec. 31, 2013 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ' | ' |
Total Proceeds From Sale Of Intangible Assets | $2,500,000 | ' |
Estimated future amortization expense of intangible assets | ' | ' |
2014 (remaining 9 months) | 19,846,000 | ' |
2015 | 25,098,000 | ' |
2016 | 24,335,000 | ' |
2017 | 23,734,000 | ' |
2018 | 10,827,000 | ' |
Thereafter | 5,420,000 | ' |
Net Carrying Amount | $109,260,000 | $117,172,000 |
Segments_and_Major_Customers_D
Segments and Major Customers (Details) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Financial information of business segments | ' | ' |
Revenues | $78,288 | $66,866 |
Segment operating expenses | 26,202 | 25,572 |
Segment operating income (loss) | 52,086 | 41,294 |
Operating income (loss) | 23,189 | 1,441 |
Interest and other income (expense), net | -9,913 | -7,332 |
Income (Loss) before income taxes | 13,276 | -5,891 |
MID Segment | ' | ' |
Financial information of business segments | ' | ' |
Revenues | 61,156 | 59,674 |
Segment operating expenses | 9,920 | 9,884 |
Segment operating income (loss) | 51,236 | 49,790 |
CRI Segment | ' | ' |
Financial information of business segments | ' | ' |
Revenues | 12,903 | 6,883 |
Segment operating expenses | 7,629 | 4,888 |
Segment operating income (loss) | 5,274 | 1,995 |
CTO Segment | ' | ' |
Financial information of business segments | ' | ' |
Revenues | 0 | 0 |
Segment operating expenses | 4,271 | 7,171 |
Segment operating income (loss) | -4,271 | -7,171 |
Other | ' | ' |
Financial information of business segments | ' | ' |
Revenues | 4,229 | 309 |
Segment operating expenses | 4,382 | 3,629 |
Segment operating income (loss) | -153 | -3,320 |
Reconciling Items | ' | ' |
Financial information of business segments | ' | ' |
Operating income (loss) | ($28,897) | ($39,853) |
Segments_and_Major_Customers_D1
Segments and Major Customers (Details 2) (Customer Concentration Risk, Sales, net) | 3 Months Ended | |
Mar. 31, 2014 | Mar. 31, 2013 | |
Customer A | ' | ' |
Concentration Risk | ' | ' |
Revenue from major customer as a percentage of total revenue | 19.00% | 33.00% |
Customer B | ' | ' |
Concentration Risk | ' | ' |
Revenue from major customer as a percentage of total revenue | 15.00% | ' |
Customer C | ' | ' |
Concentration Risk | ' | ' |
Revenue from major customer as a percentage of total revenue | 12.00% | ' |
Customer D | ' | ' |
Concentration Risk | ' | ' |
Revenue from major customer as a percentage of total revenue | ' | 15.00% |
Customer E | ' | ' |
Concentration Risk | ' | ' |
Revenue from major customer as a percentage of total revenue | ' | 10.00% |
Segments_and_Major_Customers_D2
Segments and Major Customers (Details 3) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
Major Customer Disclosure | ' | ' |
Revenues | $78,288 | $66,866 |
South Korea | ' | ' |
Major Customer Disclosure | ' | ' |
Revenues | 26,853 | 22,025 |
USA | ' | ' |
Major Customer Disclosure | ' | ' |
Revenues | 28,674 | 25,569 |
Japan | ' | ' |
Major Customer Disclosure | ' | ' |
Revenues | 9,255 | 14,609 |
Europe | ' | ' |
Major Customer Disclosure | ' | ' |
Revenues | 8,563 | 2,127 |
Canada | ' | ' |
Major Customer Disclosure | ' | ' |
Revenues | 1,824 | 1,786 |
Asia-Other | ' | ' |
Major Customer Disclosure | ' | ' |
Revenues | $3,119 | $750 |
Marketable_Securities_Details
Marketable Securities (Details) (USD $) | 3 Months Ended | 12 Months Ended |
In Thousands, unless otherwise specified | Mar. 31, 2014 | Dec. 31, 2013 |
Cash equivalents and marketable securities | ' | ' |
Maximum maturity period of available-for-sale securities (in years) | '3 years | '3 years |
Maximum remaining maturity period of available-for-sale securities (in years) | '1 year | '1 year |
Fair Value | $376,116 | $359,097 |
Amortized Cost | 376,124 | 359,112 |
Gross Unrealized Gains | 1 | 0 |
Gross Unrealized Losses | -9 | -15 |
Cash, fair value | 27,308 | 28,565 |
Cash, amortized cost | 27,308 | 28,565 |
Cash, cash equivalents and marketable securities | ' | ' |
Fair Value | 403,424 | 387,662 |
Amortized Cost | 403,432 | 387,677 |
Gross Unrealized Gains | 1 | 0 |
Gross Unrealized Losses | -9 | -15 |
Money market funds | ' | ' |
Cash equivalents and marketable securities | ' | ' |
Fair Value | 317,769 | 300,605 |
Amortized Cost | 317,769 | 300,605 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 0 | 0 |
Weighted Rate of Return (as a percent) | 0.01% | 0.01% |
Corporate notes, bonds and commercial paper | ' | ' |
Cash equivalents and marketable securities | ' | ' |
Fair Value | 58,347 | 58,492 |
Amortized Cost | 58,355 | 58,507 |
Gross Unrealized Gains | 1 | 0 |
Gross Unrealized Losses | -9 | -15 |
Weighted Rate of Return (as a percent) | 0.13% | 0.15% |
Cash equivalents and marketable securities, Continuous unrealized loss position | ' | ' |
Less than one year, Fair Value | 43,151 | 53,491 |
Unrealized gain (loss), Gross | ' | ' |
Less than one year, Gross Unrealized Loss | -9 | -15 |
Cash equivalents | ' | ' |
Cash equivalents and marketable securities | ' | ' |
Fair Value | 319,268 | 310,131 |
Short term marketable securities | ' | ' |
Cash equivalents and marketable securities | ' | ' |
Fair Value | $56,848 | $48,966 |
Fair_Value_of_Financial_Instru2
Fair Value of Financial Instruments (Details) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 |
In Thousands, unless otherwise specified | Money market funds | Money market funds | Corporate notes, bonds and commercial paper | Corporate notes, bonds and commercial paper | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Recurring basis | Nonrecurring basis | Nonrecurring basis | Nonrecurring basis | Nonrecurring basis | ||
Total | Total | Total | Total | Total | Total | Quoted Market Prices in Active Markets (Level 1) | Quoted Market Prices in Active Markets (Level 1) | Quoted Market Prices in Active Markets (Level 1) | Quoted Market Prices in Active Markets (Level 1) | Quoted Market Prices in Active Markets (Level 1) | Quoted Market Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Other Observable Inputs (Level 2) | Significant Other Observable Inputs (Level 2) | Significant Other Observable Inputs (Level 2) | Significant Other Observable Inputs (Level 2) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Significant Unobservable Inputs (Level 3) | Quoted Market Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | ||||||||
Money market funds | Money market funds | Corporate notes, bonds and commercial paper | Corporate notes, bonds and commercial paper | Money market funds | Money market funds | Corporate notes, bonds and commercial paper | Corporate notes, bonds and commercial paper | Money market funds | Money market funds | Corporate notes, bonds and commercial paper | Corporate notes, bonds and commercial paper | Money market funds | Money market funds | Corporate notes, bonds and commercial paper | Corporate notes, bonds and commercial paper | |||||||||||||||||||
Financial assets subject to fair value measurements and the necessary disclosures | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total available-for-sale securities | $376,116 | $359,097 | $317,769 | $300,605 | $58,347 | $58,492 | $376,116 | $359,097 | $317,769 | $300,605 | $58,347 | $58,492 | $317,769 | $300,605 | $317,769 | $300,605 | $0 | $0 | $58,347 | $58,492 | $0 | $0 | $58,347 | $58,492 | $0 | $0 | $0 | $0 | $0 | $0 | ' | ' | ' | ' |
Investment in non-marketable equity securities | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Carrying Value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 600 | ' | ' | ' |
Fair Value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 600 |
Impairment of investment in non-marketable equity security | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | ' | ' | ' |
Fair_Value_of_Financial_Instru3
Fair Value of Financial Instruments (Details 2) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
5% Convertible Senior Notes due 2014 | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Face Value | $172,500 | $172,500 |
Convertible Notes Payable | 168,658 | 164,047 |
Fair Value | 173,846 | 175,821 |
Convertible notes stated interest rate (as a percent) | 5.00% | 5.00% |
1.125% Convertible Senior Notes due 2018 | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Face Value | 138,000 | 138,000 |
Convertible Notes Payable | 110,962 | 109,629 |
Fair Value | $155,824 | $142,427 |
Convertible notes stated interest rate (as a percent) | 1.13% | 1.13% |
Convertible_Notes_Details
Convertible Notes (Details) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Debt Instrument [Line Items] | ' | ' |
Convertible notes, short-term | $168,658 | $164,047 |
Convertible notes, long-term | 110,962 | 109,629 |
Convertible Senior Notes [Member] | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Principal amount of convertible notes | 310,500 | 310,500 |
Unamortized discount | -30,880 | -36,824 |
Total convertible notes | 279,620 | 273,676 |
Convertible notes, short-term | 168,658 | 164,047 |
Convertible notes, long-term | 110,962 | 109,629 |
Convertible Senior Notes [Member] | 5% Convertible Senior Notes due 2014 | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Convertible notes stated interest rate (as a percent) | 5.00% | 5.00% |
Principal amount of convertible notes | 172,500 | 172,500 |
Unamortized discount | -3,842 | -8,453 |
Convertible Senior Notes [Member] | 1.125% Convertible Senior Notes due 2018 | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Convertible notes stated interest rate (as a percent) | 1.13% | 1.13% |
Principal amount of convertible notes | 138,000 | 138,000 |
Unamortized discount | ($27,038) | ($28,371) |
Convertible_Notes_Details_2
Convertible Notes (Details 2) (Convertible Senior Notes [Member], USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Debt Instrument [Line Items] | ' | ' |
Principal amount of convertible notes | $310,500 | $310,500 |
1.125% Convertible Senior Notes due 2018 | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Principal amount of convertible notes | $138,000 | $138,000 |
Convertible notes stated interest rate (as a percent) | 1.13% | 1.13% |
Convertible_Notes_Details_3
Convertible Notes (Details 3) (USD $) | 3 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Dec. 31, 2013 |
Interest expense related to notes | ' | ' | ' |
Amortization of discount and debt issuance costs | $6,242 | $4,089 | ' |
Interest expense | 9,926 | 7,312 | ' |
Convertible Senior Notes [Member] | ' | ' | ' |
Interest expense related to notes | ' | ' | ' |
Interest expense | 8,786 | 6,246 | ' |
Convertible Senior Notes [Member] | 5% Convertible Senior Notes due 2014 | ' | ' | ' |
Debt Instrument [Line Items] | ' | ' | ' |
Additional Effective Interest Rate | 11.70% | 11.70% | ' |
Interest expense related to notes | ' | ' | ' |
Interest | 2,156 | 2,157 | ' |
Amortization of discount and debt issuance costs | 4,769 | 4,089 | ' |
Convertible notes stated interest rate (as a percent) | 5.00% | ' | 5.00% |
Convertible Senior Notes [Member] | 1.125% Convertible Senior Notes due 2018 | ' | ' | ' |
Debt Instrument [Line Items] | ' | ' | ' |
Additional Effective Interest Rate | 5.50% | 5.50% | ' |
Interest expense related to notes | ' | ' | ' |
Interest | 388 | 0 | ' |
Amortization of discount and debt issuance costs | $1,473 | $0 | ' |
Convertible notes stated interest rate (as a percent) | 1.13% | ' | 1.13% |
Commitments_and_Contingencies_1
Commitments and Contingencies (Details) (USD $) | 3 Months Ended | |||
Mar. 31, 2014 | Mar. 31, 2013 | Dec. 31, 2013 | ||
Contractual obligations | ' | ' | ' | |
Contractual Obligation | $390,159,000 | [1] | ' | ' |
Remainder of 2014 | 203,535,000 | [1] | ' | ' |
2015 | 12,616,000 | [1] | ' | ' |
2016 | 9,325,000 | [1] | ' | ' |
2017 | 8,873,000 | [1] | ' | ' |
2018 | 146,339,000 | [1] | ' | ' |
Thereafter | 9,471,000 | [1] | ' | ' |
Unrecognized tax benefits | 20,000,000 | ' | 18,800,000 | |
Unrecognized tax benefits, reduction of long-term deferred tax assets | 18,000,000 | ' | 12,600,000 | |
Unrecognized tax benefits included in long-term income taxes payable | 2,000,000 | ' | 6,200,000 | |
Terms of noncancellable license agreement, minimum (in years) | '1 year | ' | ' | |
Remaining CRI retention bonuses payable | 16,700,000 | ' | ' | |
Rent expense | 600,000 | 900,000 | ' | |
Deferred rent | 1,300,000 | ' | 1,400,000 | |
Imputed financing obligation | ' | ' | ' | |
Contractual obligations | ' | ' | ' | |
Contractual Obligation | 38,808,000 | [1],[2] | ' | ' |
Remainder of 2014 | 4,422,000 | [1],[2] | ' | ' |
2015 | 6,010,000 | [1],[2] | ' | ' |
2016 | 6,156,000 | [1],[2] | ' | ' |
2017 | 6,302,000 | [1],[2] | ' | ' |
2018 | 6,447,000 | [1],[2] | ' | ' |
Thereafter | 9,471,000 | [1],[2] | ' | ' |
Leases and other contractual obligations | ' | ' | ' | |
Contractual obligations | ' | ' | ' | |
Contractual Obligation | 7,118,000 | [1] | ' | ' |
Remainder of 2014 | 2,399,000 | [1] | ' | ' |
2015 | 2,118,000 | [1] | ' | ' |
2016 | 1,243,000 | [1] | ' | ' |
2017 | 1,018,000 | [1] | ' | ' |
2018 | 340,000 | [1] | ' | ' |
Thereafter | 0 | [1] | ' | ' |
Software licenses | ' | ' | ' | |
Contractual obligations | ' | ' | ' | |
Contractual Obligation | 5,684,000 | [1],[3] | ' | ' |
Remainder of 2014 | 2,446,000 | [1],[3] | ' | ' |
2015 | 2,865,000 | [1],[3] | ' | ' |
2016 | 373,000 | [1],[3] | ' | ' |
2017 | 0 | [1],[3] | ' | ' |
2018 | 0 | [1],[3] | ' | ' |
Thereafter | 0 | [1],[3] | ' | ' |
Acquisition retention bonuses | ' | ' | ' | |
Contractual obligations | ' | ' | ' | |
Contractual Obligation | 16,749,000 | [1],[4] | ' | ' |
Remainder of 2014 | 16,679,000 | [1],[4] | ' | ' |
2015 | 70,000 | [1],[4] | ' | ' |
2016 | 0 | [1],[4] | ' | ' |
2017 | 0 | [1],[4] | ' | ' |
2018 | 0 | [1],[4] | ' | ' |
Thereafter | 0 | [1],[4] | ' | ' |
Convertible notes | ' | ' | ' | |
Contractual obligations | ' | ' | ' | |
Contractual Obligation | 310,500,000 | [1] | ' | ' |
Remainder of 2014 | 172,500,000 | [1] | ' | ' |
2015 | 0 | [1] | ' | ' |
2016 | 0 | [1] | ' | ' |
2017 | 0 | [1] | ' | ' |
2018 | 138,000,000 | [1] | ' | ' |
Thereafter | 0 | [1] | ' | ' |
Interest payments related to convertible notes | ' | ' | ' | |
Contractual obligations | ' | ' | ' | |
Contractual Obligation | 11,300,000 | [1] | ' | ' |
Remainder of 2014 | 5,089,000 | [1] | ' | ' |
2015 | 1,553,000 | [1] | ' | ' |
2016 | 1,553,000 | [1] | ' | ' |
2017 | 1,553,000 | [1] | ' | ' |
2018 | 1,552,000 | [1] | ' | ' |
Thereafter | $0 | [1] | ' | ' |
[1] | The above table does not reflect possible payments in connection with uncertain tax benefits of approximately $20.0 million including $18.0 million recorded as a reduction of long-term deferred tax assets and $2.0 million in long-term income taxes payable as of March 31, 2014. As noted below in Note 13, “Income Taxes,†although it is possible that some of the unrecognized tax benefits could be settled within the next 12 months, the Company cannot reasonably estimate the outcome at this time. | |||
[2] | With respect to the imputed financing obligation, the main components of the difference between the amount reflected in the contractual obligations table and the amount reflected on the condensed consolidated balance sheets are the interest on the imputed financing obligation and the estimated common area expenses over the future periods. Additionally, the amount includes the amended Ohio lease and the amended Sunnyvale lease. | |||
[3] | The Company has commitments with various software vendors for non-cancellable license agreements generally having terms longer than one year. The above table summarizes those contractual obligations as of March 31, 2014 which are also presented on the Company’s condensed consolidated balance sheet under current and other long-term liabilities. | |||
[4] | In connection with acquisitions, the Company is obligated to pay retention bonuses to certain employees and contractors, subject to certain eligibility and acceleration provisions including the condition of employment. The remaining $16.7 million of CRI retention bonuses payable on June 3, 2014 can be paid in cash or stock at the Company’s election. |
Equity_Incentive_Plans_and_Sto2
Equity Incentive Plans and Stock-Based Compensation (Details) (Stock-Based Incentive Compensation Plans) | 0 Months Ended | 3 Months Ended | |
Apr. 26, 2012 | Mar. 31, 2014 | ||
Stock-Based Incentive Compensation Plans | ' | ' | |
Stock-Based Compensation | ' | ' | |
Number of shares reserved under the 2006 Purchase Plan | ' | 21,400,000 | |
Shares available for grant | ' | ' | |
Shares available, at the beginning of the year | ' | 2,527,428 | |
Increase in shares approved for issuance | 6,500,000 | ' | |
Stock options granted (in shares) | ' | -1,797,462 | |
Stock options forfeited (in shares) | ' | 269,083 | |
Stock options expired under former plans (in shares) | ' | -9,900 | |
Nonvested equity stock and stock units granted (in shares) | ' | -308,712 | [1] |
Nonvested equity stock and stock units forfeited (in shares) | ' | 19,621 | [1] |
Shares available, at the end of the period | ' | 700,058 | |
Conversion factor used to calculate the decrease in the number of shares available for grant resulting from the grant of restricted stock awards | ' | 1.5 | |
Conversion factor used to calculate the increase in the number of shares available for grant resulting from the forfeiture of restricted stock awards | ' | 1.5 | |
[1] | For purposes of determining the number of shares available for grant under the 2006 Plan against the maximum number of shares authorized, each share of restricted stock granted reduces the number of shares available for grant by 1.5 shares and each share of restricted stock forfeited increases shares available for grant by 1.5 shares. |
Equity_Incentive_Plans_and_Sto3
Equity Incentive Plans and Stock-Based Compensation (Details 2) (Stock Option Plans, USD $) | 3 Months Ended | |||
In Thousands, except Share data, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 |
Stock Options with Market Condition | Stock Options with Market Condition | |||
Number of Shares | ' | ' | ' | ' |
Outstanding, at the beginning of the period (in shares) | 11,377,146 | ' | 1,315,000 | 1,315,000 |
Options granted (in shares) | 1,797,462 | 1,619,437 | ' | ' |
Options exercised (in shares) | -206,843 | ' | ' | ' |
Options forfeited (in shares) | -269,083 | ' | ' | ' |
Outstanding, at the end of the period (in shares) | 12,698,682 | ' | 1,315,000 | 1,315,000 |
Vested or expected to vest at the end of the period (in shares) | 11,752,766 | ' | ' | ' |
Options exercisable at the end of the period (in shares) | 6,303,547 | ' | ' | ' |
Weighted Average Exercise Price | ' | ' | ' | ' |
Outstanding at the beginning of the year (in dollars per shares) | $11.32 | ' | ' | ' |
Options granted (in dollars per share) | $8.78 | ' | ' | ' |
Options exercised (in dollars per share) | $6.73 | ' | ' | ' |
Options forfeited (in dollars per share) | $15.20 | ' | ' | ' |
Outstanding at the end of the period (in dollars per shares) | $10.95 | ' | ' | ' |
Vested or expected to vest at the end of the period (in dollars per share) | $11.25 | ' | ' | ' |
Options exercisable at the end of the period (in dollars per share) | $14.94 | ' | ' | ' |
Weighted Average Remaining Contractual Term | ' | ' | ' | ' |
Outstanding | '6 years 1 month 16 days | ' | ' | ' |
Vested or expected to vest | '5 years 10 months 28 days | ' | ' | ' |
Options exercisable | '3 years 8 months 26 days | ' | ' | ' |
Aggregate Intrinsic Value | ' | ' | ' | ' |
Outstanding | $36,153 | ' | ' | ' |
Vested or expected to vest | 32,643 | ' | ' | ' |
Options exercisable | $10,850 | ' | ' | ' |
Closing stock price (in dollars per share) | $10.75 | ' | ' | ' |
Total number of in-the-money outstanding (in shares) | 8,833,026 | ' | ' | ' |
Total number of in-the-money exercisable (in shares) | 2,656,578 | ' | ' | ' |
Equity_Incentive_Plans_and_Sto4
Equity Incentive Plans and Stock-Based Compensation (Details 3) (USD $) | 0 Months Ended | 3 Months Ended | |
Sep. 27, 2013 | Mar. 31, 2014 | Mar. 31, 2013 | |
Valuation assumptions | ' | ' | ' |
Dividend yield (as a percent) | ' | 0.00% | ' |
Employee Stock Purchase Plan | ' | ' | ' |
Stock-Based Compensation | ' | ' | ' |
Shares available for issuance | ' | 19,232 | ' |
Number of additional shares registered under the ESPP | 1,500,000 | ' | ' |
Shares issued at discount from the fair market value (as a percent) | ' | 15.00% | ' |
Stock-based compensation | ' | ' | $500,000 |
Expected weighted-average period for recognition of compensation cost | ' | '1 month | ' |
Stock Option Plans | ' | ' | ' |
Stock-Based Compensation | ' | ' | ' |
Stock options granted (in shares) | ' | 1,797,462 | 1,619,437 |
Estimated total grant date fair value | ' | 7,000,000 | 3,800,000 |
Stock-based compensation | ' | 2,200,000 | 3,100,000 |
Unrecognized compensation cost net of expected forfeitures | ' | 19,400,000 | ' |
Expected weighted-average period for recognition of compensation cost | ' | '2 years 6 months 11 days | ' |
Total fair value of options vested | ' | 63,400,000 | ' |
Total intrinsic value of options exercised | ' | 600,000 | ' |
Proceeds from Stock Options Exercised | ' | 1,400,000 | ' |
Valuation assumptions | ' | ' | ' |
Expected stock price volatility (as a percent) | ' | 44.00% | 47.00% |
Risk free interest rate | ' | 2.10% | 0.90% |
Expected term | ' | '6 years 0 months 29 days | '5 years 4 months 24 days |
Weighted-average fair value of stock options granted (in dollars per share) | ' | 3.92 | $2.33 |
Restricted Stock and Stock Units | ' | ' | ' |
Stock-Based Compensation | ' | ' | ' |
Stock-based compensation | ' | 700,000 | 1,300,000 |
Unrecognized compensation cost net of expected forfeitures | ' | 4,300,000 | ' |
Expected weighted-average period for recognition of compensation cost | ' | '2 years 7 months 6 days | ' |
Valuation assumptions | ' | ' | ' |
General nonvested equity stock service period (in years) | ' | '4 years | ' |
Nonvested equity stock unit to directors, service period | ' | '1 year | ' |
Total fair value of nonvested equity stock units at grant date | ' | 1,800,000 | $1,500,000 |
Nonvested equity stock and stock units | ' | ' | ' |
Nonvested at the beginning of the period (in shares) | ' | 629,649 | ' |
Granted (in shares) | ' | 205,808 | 276,496 |
Vested (in shares) | ' | -117,828 | ' |
Forfeited (in shares) | ' | -13,078 | ' |
Nonvested at the end of the period (in shares) | ' | 704,551 | ' |
Weighted-Average Grant-Date Fair Value | ' | ' | ' |
Nonvested at the beginning of the period (in dollars per share) | ' | 8.56 | ' |
Granted (in dollars per share) | ' | 8.79 | ' |
Vested (in dollars per share) | ' | 9.56 | ' |
Forfeited (in dollars per share) | ' | 6.67 | ' |
Nonvested at the end of the period (in dollars per share) | ' | 8.49 | ' |
Stockholders_Equity_Details
Stockholders' Equity (Details) (USD $) | Mar. 31, 2014 |
In Millions, unless otherwise specified | |
Share repurchase program | ' |
Cumulative shares that have been repurchased in stock repurchase program | 26.3 |
Cumulative value of shares repurchased in stock repurchase program | $428.90 |
Remaining shares authorized to be repurchased | 5.2 |
Restructuring_Charges_Details
Restructuring Charges (Details) (USD $) | 3 Months Ended | |
Mar. 31, 2014 | Mar. 31, 2013 | |
Restructuring Cost and Reserve | ' | ' |
Restructuring charges | $39,000 | $2,206,000 |
Restructuring Reserve [Roll Forward] | ' | ' |
Restructuring charges | 39,000 | 2,206,000 |
2013 Plan | ' | ' |
Restructuring Cost and Reserve | ' | ' |
Restructuring charges | 39,000 | ' |
Restructuring Reserve [Roll Forward] | ' | ' |
Beginning Balance | 1,865,000 | ' |
Restructuring charges | 39,000 | ' |
Payments | -1,746,000 | ' |
Ending Balance | 158,000 | ' |
2013 Plan | Minimum | ' | ' |
Restructuring Cost and Reserve | ' | ' |
Company estimate of the aggregate restructuring cost | 3,000,000 | ' |
2013 Plan | Maximum | ' | ' |
Restructuring Cost and Reserve | ' | ' |
Company estimate of the aggregate restructuring cost | 4,000,000 | ' |
2013 Plan | Employee Severance and Related Benefits | ' | ' |
Restructuring Cost and Reserve | ' | ' |
Restructuring charges | 39,000 | ' |
Restructuring Reserve [Roll Forward] | ' | ' |
Beginning Balance | 1,732,000 | ' |
Restructuring charges | 39,000 | ' |
Payments | -1,613,000 | ' |
Ending Balance | 158,000 | ' |
2013 Plan | Facilities | ' | ' |
Restructuring Cost and Reserve | ' | ' |
Restructuring charges | 0 | ' |
Restructuring Reserve [Roll Forward] | ' | ' |
Beginning Balance | 133,000 | ' |
Restructuring charges | 0 | ' |
Payments | -133,000 | ' |
Ending Balance | $0 | ' |
Income_Taxes_Details
Income Taxes (Details) (USD $) | 3 Months Ended | ||
Mar. 31, 2014 | Mar. 31, 2013 | Dec. 31, 2013 | |
Income Tax Disclosure [Abstract] | ' | ' | ' |
Provision for income taxes | $5,472,000 | $4,511,000 | ' |
Payment of withholding taxes to foreign tax authorities | 5,100,000 | 3,800,000 | ' |
Deferred Tax Assets, Gross | 188,700,000 | ' | ' |
Unrecognized tax benefits | 20,000,000 | ' | 18,800,000 |
Unrecognized tax benefits, reduction of long-term deferred tax assets | 18,000,000 | ' | 12,600,000 |
Unrecognized tax benefits included in long-term income taxes payable | 2,000,000 | ' | 6,200,000 |
Portion of unrecognized tax benefits, which if recognized, would be recorded as an income tax benefit | $2,000,000 | ' | ' |
Agreement_with_SK_hynix_and_Mi2
Agreement with SK hynix and Micron (Details) (USD $) | Mar. 31, 2014 | Jun. 11, 2013 | Mar. 31, 2014 | Dec. 09, 2013 |
In Millions, unless otherwise specified | SK hynix [Member] | SK hynix [Member] | Micron [Member] | Micron [Member] |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ' | ' | ' | ' |
Term of patent license agreement | ' | '5 years | ' | '7 years |
Amount to be paid quarterly | $12 | ' | $10 | ' |
Future Receivables | $204 | ' | $264.50 | ' |
Agreement_with_SK_hynix_and_Mi3
Agreement with SK hynix and Micron (Details 2) (Details) (USD $) | 3 Months Ended | 4 Months Ended | 3 Months Ended | 4 Months Ended | 3 Months Ended | 4 Months Ended | 3 Months Ended | 10 Months Ended | 3 Months Ended | 10 Months Ended | 3 Months Ended | 10 Months Ended |
In Millions, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 |
Micron [Member] | Micron [Member] | Micron [Member] | Micron [Member] | Micron [Member] | Micron [Member] | SK hynix [Member] | SK hynix [Member] | SK hynix [Member] | SK hynix [Member] | SK hynix [Member] | SK hynix [Member] | |
Royalty revenue | Royalty revenue | Gain from settlement | Gain from settlement | Royalty revenue | Royalty revenue | Gain from settlement | Gain from settlement | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash Received to date in 2014 | $10 | $15.50 | $9.70 | $15 | $0.30 | $0.50 | $12 | $36 | $11.80 | $35.40 | $0.20 | $0.60 |
Estimated to Be Received in Remainder of 2014 | 30 | 30 | 29 | 29 | 1 | 1 | 36 | 36 | 35.5 | 35.5 | 0.5 | 0.5 |
Estimated to Be Received in 2015 | 40 | 40 | 38.7 | 38.7 | 1.3 | 1.3 | 48 | 48 | 47.3 | 47.3 | 0.7 | 0.7 |
Estimated to Be Received in 2016 | 40 | 40 | 39.5 | 39.5 | 0.5 | 0.5 | 48 | 48 | 47.9 | 47.9 | 0.1 | 0.1 |
Estimated to Be Received in 2017 | 40 | 40 | 40 | 40 | 0 | 0 | 48 | 48 | 48 | 48 | 0 | 0 |
Estimated to Be Received in 2018 | 40 | 40 | 40 | 40 | 0 | 0 | 24 | 24 | 24 | 24 | 0 | 0 |
Estimated to Be Received in 2019 and thereafter | 74.5 | 74.5 | 74.5 | 74.5 | 0 | 0 | ' | ' | ' | ' | ' | ' |
Total Estimated Cash receipts | $280 | $280 | $276.70 | $276.70 | $3.30 | $3.30 | $240 | $240 | $238.10 | $238.10 | $1.90 | $1.90 |